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ABSTRACT 
An efficient and regulated immune system is required for protection against pathogens. B 
cells are required for a humoral response. For a sustained humoral response against pathogens 
germinal center (GC) reactions are required. In the GC reaction, B cells with antigen-specific 
B cell receptors are selected and expanded. The GC contains follicular dendritic cells (FDCs) 
presenting antigens to the B cells, T follicular helper cells promoting proliferation of cognate 
B cells and highly proliferating B cells expressing activation induced deaminase (AID) in 
order to produce high-affinity and isotype-switched antibodies.  
In this thesis I aimed to define the unique and redundant functions of two actin-polymerizing 
proteins, WASp and N-WASp, the importance of the RhoGTPase Cdc42 and the 
consequences of mutated AID in the GC reaction. In paper I we discovered that naïve 
WASp-deficient (WKO) mice and WASp-deficient mice with N-WASp conditionally deleted 
only in B cells (cDKO) had increased titers of autoreactive antibodies (IgG and IgM, 
respectively). Both WKO and cDKO B cells got sufficient help from cognate T cells, while 
the polarization of GCs and the FDC network was altered upon autoantigen challenge. cDKO 
mice may have increased activation threshold of the B cell receptor in B cells resulting in 
reduced autoreactive IgG. In paper II we revealed the distinctive and partly redundant 
function of WASp and N-WASp in B cells. We observed reduced marginal zone cellularity in 
WKO mice and even more pronounced in cDKO mice when compared with wild type mice. 
The mild phenotype of reduced GC and humoral response in WKO mice previously reported 
was markedly defected in cDKO mice after antigen challenge, promoting the notion of 
overlapping functions of WASp and N-WASp in B cells. In paper III we investigated the 
role of Cdc42, that activates both WASp and N-WASp, in B cells. Mice with deleted Cdc42 
conditionally in B cells had reduced marginal zone and follicular B cell numbers and 
reduced GC B cell number associated with reduced specific antibody titers in serum after 
antigen challenge. In paper IV we identified a mouse model for one of the most common 
mutations in AID leading to the hyper-IgM syndrome. The replacement mutation in amino 
acid position 112 resulted in a catalytic dead AID protein with spontaneous GC formation, 
and lack of high affinity or class-switched antibodies.  
Altogether, the work presented in this thesis enlightens the significance of tightly regulated 
B cells for a sufficient, and not autoreactive, humoral immune response. Specifically, this 
thesis has contributed to our understanding of the importance of a functional AID protein in 
B cells. Moreover, this thesis has helped in defining the precise activation of the actin 
regulating proteins in B cells to form antigen-induced GCs and for production of class-
switched antibodies with high affinity for the antigen.  
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1 INTRODUCTION 
1.1 THE IMMUNE SYSTEM 
The immune system is important for protection against foreign pathogens like virus, bacteria 
and other microbes. The first lines of defense against infections are the physical and chemical 
barriers that stop pathogens from entering the body. These barriers include the skin, hair, 
mucous membranes and production of antimicrobial substances. The second line of defense, 
the immune system, is activated when the pathogen has reached internal tissues and an 
immune response is initiated.  
 
1.1.1 The innate immune system 
Classically, all immunological reactions have been divided into two branches, the innate and 
the adaptive immune system, depending on if the receptor recognizing pathogen is encoded in 
the germline DNA or if gene rearrangement is required1,2. Innate immunity represents the 
first response in an immune reaction and this response is fast and has no ability to form 
efficient memory responses. The innate immune response recognizes a foreign pathogen by 
two strategies. First, by identifying markers that are characteristic to the pathogen and not 
present in the host. Second, by recognition of “missing-self”, where the pathogen lacks 
expression of markers normally expressed by host cells3,4.  
Cells constituting the innate immune repertoire include monocytes, macrophages, dendritic 
cells (DCs), innate lymphoid cells (ILCs, which includes natural killer (NK) cells) and 
granulocytes (eosinophils, basophils, neutrophils, mast cells). These cells either express 
pattern recognition receptors (PRRs) or they are recruited to the site of interest by cells 
expressing PRRs. This family of receptors identify pathogens through recognition of 
pathogen-associated molecular patterns (PAMPs)5. The PRR-family includes several 
receptors such as Toll-like receptors (TLRs), C-type lectin receptors (CLRs), nucleotide-
binding oligomerization domain (NOD)-like receptors (NLRs), retinoic acid-inducible gene-I 
(RIG-I)-like receptors (RLRs) and scavenger receptors6,7. The TLRs, CLRs and the scavenger 
receptors are transmembrane proteins while the NLRs and RLRs are located in the cytosol 
and bind intracellular PAMPs. PRRs also recognize endogenous molecules – damage-
associated molecular patterns (DAMPs), released from host cells as a result of necrosis, 
damage and pathogen infection6. The TLRs can be expressed either on the cell surface 
(TLR1, TLR2, TLR4, TLR5, TLR6) or in the lumen of intracellular vesicles (TLR3, TLR7, 
TLR8, TLR9, TLR11, TLR13) such as endoplasmic reticulum, endosomes, lysosomes and 
endolysosomes 8. The intracellular localization of TLRs enables recognition of nucleic acids 
from viruses and other pathogens in the cytosol of infected cells, thus providing important 
protection against infectious agents. However, intracellular TLRs entail the risk of unwanted 
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immune responses directed against the host’s own nucleic acids and therefore proper 
localization and trafficking of TLRs is required.  
In addition to the two main groups of innate and adaptive leukocytes, there are two groups of 
cells that fit into neither. The first group is the ILCs. As the name implies these cells are 
derived from the common lymphoid precursors (CLPs), which normally are considered 
precursors of cells belonging to the adaptive immunity, with exclusion of NK cells - which 
are a part of the ILCs. Three main features define ILCs: their antigen receptor is encoded in 
the germline DNA and does not require rearrangement by recombination activating gene 
(RAG); they lack myeloid cell and DC phenotypically markers; and they have a lymphoid 
morphology9,10.  
The second group of cells includes four cell populations; B1 B cells, marginal zone (MZ) B 
cells, γδ T cells and natural killer T (NKT) cells11-13. These populations form a part of the 
adaptive immune system but are characteristically different from the conventional 
lymphocyte cells. They all have B cell receptors (BCRs) or T cell receptors (TCRs) that 
require RAG-dependent rearrangement, but the antigen receptors are poorly diversified. The 
B1 B cells are dominant in the peritoneal cavity but also found in the spleen, where the MZ B 
cells are located. These two innate-like B cell populations produce natural antibodies14, a 
pool of antibodies occurring without previous antigen challenge. Natural antibodies are 
primarily immunoglobulin M (IgM) but also include IgG and IgA. Their characteristic 
features are polyreactivity, low affinity for the antigen, and a high frequency of 
autoreactivity15,16. Natural antibodies can be considered a part of the innate immune system 
since they are involved in neutralization of pathogens, activation of the complement cascade 
and clearance of apoptotic cells16,17. Activation-induced cytidine deaminase (AID)-deficient 
mice lack IgG antibodies and they have an increased risk of infections. By passive 
immunization with IgG antibodies, the AID-deficient mice are protected against bacterial 
infection indicating that natural antibodies are a part of the innate immune system18.  
 
1.1.2 The adaptive immune system 
Compared to the innate immune system the adaptive immunity is more complex and the 
response peaks usually 7–14 days after recognition of a foreign pathogen. The response is 
slow because the antigen has to be taken up and processed by antigen presenting cells (APCs) 
and introduced to the T (thymus-derived) and B (bursa- or bone-marrow-derived) 
lymphocytes representing the adaptive immunity. The hallmark of the adaptive immune 
response is memory; it remembers pathogens from previous encounters. Immunological 
memory enables the immune system to mount a rapid secondary response upon re-exposure 
to the pathogen. However, the possibility to remember antigens together with an effective 
immune response involving many cell types with the ability to mutate and change their 
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antigen-recognition receptor make the adaptive immune system a risk factor in terms of 
autoimmunity2.  
 
1.1.3 B cell development - from bone marrow to spleen  
In the early 1970s when the first expansive review of the T and B lymphocytes were 
published, the site of B cell development in mammals was still not clear19. Since then, these 
two cell types of the adaptive immune system have been extensively studied.  
Today it is know that conventional B cells, or B2 B cells, are derived from hematopoietic 
stem cells (HSCs) in primary lymphoid organs (fetal liver and bone marrow after birth) and 
migrate to secondary lymphoid organs (mainly spleen and lymph nodes) during development. 
The B cell development described in this section is focused mainly on B2 B cells. The 
development of B1 B cells is debated and less understood. B1 B cells, mentioned in the 
innate immune system section, most probably have another maturation pathway that is 
different from B2 B cells. Some distinct differences between the B cell subsets are that B1 B 
cells have intermediate rather than high B220 expression, cluster of differentiation (CD) 
CD11b+ (Mac-1, in peritoneal cavity), CD5+ (B1a), natural antibody production and ability of 
self-renewal. Transplantation studies with adult bone marrow or neonatal liver show that 
adult bone marrow does repopulate the B2 B cells while the B1 cell population is less 
satisfactory repopulated. However, transplantation of neonatal liver cells repopulate both 
populations efficiently, suggesting that B1 and B2 cells develop separately20. During 
embryonic development the bone marrow is populated by stem cells originating from fetal 
liver. Both B1 and B2 B cells develop from HSCs to CLPs through multilineage progenitors 
(MLPs). The CLP subset can only give rise to lymphocytes (i.e. T, B and NK cells) and is 
directly prior to B linage commitment where the cells become B lineage restricted and 
express B22021. 
A key regulator of early B cell development is interleukin-7 (IL-7) produced by stromal cells 
in the fetal liver, bone marrow, thymus and spleen. The IL-7 receptor α chain is upregulated 
on CLP cells. IL-7 or IL-7 receptor-deficient mice have a severe block in early B cell 
development22,23. The B cells that are found in the periphery of these mice are of MZ and B1 
B cell phenotype24. These cells originate from the fetal liver where IL-7 has shown not to be 
absolutely required for B cell development25,26. In contrast to murine B2 lymphocytes 
development it has been shown that human B cell generation is largely or entirely IL-7-
independent. Comparable to the mouse data, B cells produced in patients with a defective IL-
7 receptor α  subunit expression come from fetal or neonatal development, although the exact 
origin and development are not yet fully understood26,27.  
After lineage commitment the B cell development can be divided into several maturation 
stages. There are three different nomenclatures of early B lineage cells; Basel nomenclature, 
Philadelphia nomenclature and the “the Hardy fractions” (described 1991 by Richard Hardy 
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and colleagues) (Table 1)28,29. Since the Hardy classification and the Philadelphia 
nomenclature are used in the papers included in this thesis, I will mainly refer to the Hardy 
classification with the Philadelphia nomenclature in parenthesis.  
 
Hardy 
classification 
Fraction A Fraction B/C Fraction C´ Fraction D Fraction E 
Philadelphia 
nomenclature 
Pre-pro B cell Pro B cell Early pre B 
cell 
Late pre B 
cell 
Immature B 
cell 
Basel 
nomenclature 
Pro B cell Pre B-I cell Pre B-I cell Pre B-II cell  
Table 1. Nomenclature of B cells in the bone marrow28. 
 
The first stage, fraction A (pre-pro B cell), can be recognized by expression of CD43+, B220+ 
and absence of CD19 and CD24 (heat stable antigen, HSA) expression 30. Specificity for the 
B cell linage comes from activation of the helix–loop–helix protein E2A and the early B cell 
factor 1 (EBF1) which activate B-lymphoid genes, such as Igα and Igβ which are important 
for intracellular signaling of the BCR later on. Mice with either of these transcriptions factors 
mutated have a B cell arrest prior fraction A31. Fraction A has little, if any, gene 
rearrangement of the BCR32. Sequential gene rearrangement of the antigen receptor is found 
first in the next stage, fraction B/C (pro B cell) that expresses all four markers CD43+, B220+, 
CD19+, CD24+ but still does not express a pre-BCR or BCR on the cell surface29. B220 and 
CD19 are two markers commonly used to characterize mouse B cells in the periphery.  
The antigen receptor gene rearrangement is called V(D)J recombination, and induces 
recombination of the variable (V), diversity (D) and joining (J) segments. V(D)J segment 
recombination requires the expression of the proteins RAG1 and RAG233,34. Two factors 
controlling the V to DJ rearrangement are IL-7 and the transcription factor paired box protein 
5 (Pax5)35,36. If successful rearrangement of the immunoglobulin heavy (IgH) chain locus 
occurs the cell goes into fraction C´ (early pre B cell). This fraction is the last to express 
CD43 – cells in transition from pro-B to pre-B. The fractions A, B, C and C´ can be separated 
by their surface expression of CD24 and beta protein 1 (BP-1). Fraction C´ is the first fraction 
to express the pre-BCR on the cell surface.  
The pre-BCR is important for testing the potential binding capacity of the IgH chain, called 
positive selection. If the IgH chain is autoreactive it may undergo additional rounds of 
rearrangement to get a functional IgH chain. The pre-BCR is formed by the rearranged IgH 
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(Igµ) and the Ig light-(IgL) chain-like structure; the surrogate light chain (SLC). The SLC 
consists of two proteins: VpreB and λ5. SLC-deficient mice have impaired B cell 
development after fraction B/C (pro B cell) and have increased levels of autoreactive IgM 
antibodies produced by MZ B cells37-39. In the pre-BCR complex there is also the 
transmembrane signaling proteins, Igα (CD79a) and Igβ (CD79b). The enzyme spleen 
tyrosine kinase (SYK) can phosphorylate tyrosine residues on Igα’s and Igβ’s cytoplasmic 
domains, immunoreceptor tyrosine-based activation motif (ITAM), and signaling molecules 
such as Bruton’s tyrosine kinase (Btk) can bind to the phosphorylated structure and promote 
pre-BCR and BCR signaling by stimulating Ca2+ flux40. The BCR is built up by four 
components, two IgH chains and two IgL chains, which consist of either Igκ or Igλ (only in 
5% of murine B cells)41. Like the pre-BCR, the BCR has Igα and Igβ associated to it. V(D)J 
rearrangement of the IgH chain occurs in fraction B/C while for IgL locus it occurs in 
fraction D (late pre-B cell). At this stage, 5 x 1013 different antibody specificities recognizing 
antigen epitopes could theoretically be formed, depending on the IgH chain variation. Many 
of the formed clones will be excluded later on because of unwanted affinities, for example 
too strong reactivity to autoantigens42. RAG-expression is tightly regulated and almost 
exclusively expressed during this part of B cell maturation. However, there is one B cell 
population which develops in the lamina propria and undergoes RAG-dependent V(D)J 
recombination in the mouse intestine43. Another exception is a GC B cell subset that are able 
to turn on the expression of λ5 and RAG1 and RAG2, to make V(D)J recombination possible 
in the periphery44. However, Gärtner et al. together with other groups suggest that these 
RAG-positive B cells in the periphery actually are progenitor/precursor B cells from the bone 
marrow accumulated in the spleen45.  
In the progression from fraction D to fraction E (immature B cell) the B cell’s newly formed 
BCR is tested for potential autoreactivity in order to eliminate autoreactive B cells in the 
central tolerance checkpoint. This negative selection results either in deletion of the cell or 
new recombination of the already existing BCR. Receptor editing involves mainly the IgL 
chain since the IgH chain is tested during the pre-BCR process. Receptor editing includes re-
expression of RAG proteins so that new gene rearrangement can occur46. Productive 
rearrangement of both IgH and IgL chains in pre-B cells which induces BCR signaling, 
results in immature IgM+ B cells that can leave the bone marrow and migrate to the spleen 
and other secondary lymphoid organs to take part in humoral immune responses28. Of the 1-2 
x 107 IgM+ immature B cells developed every day only 10% leaves the bone marrow as 
transitional B cells47.  
So far, three subsets of transitional B cells have been identified and defined by their surface 
phenotype (in mouse; T1, T2 and T3). The two first subsets were found by using the surface 
markers for B220, CD23 (FcεRII), CD21 (complement receptor 2) and IgM. T1 cells can be 
separated from T2 cells by lack of IgD, CD23 and CD21 protein expression48. In 2001 
Allman and colleagues characterized the third population first by positive selection on 
B220+CD93+ (AA4.1) cells and then separating the population by IgM and CD23 
 6 
expression49. More recent studies on the T3 subset in mice suggest that this population might 
represent anergic cells that that will not progress into mature B cells50,51.  
Transitional B cells are short lived and only one third of the transitional B cells become 
mature B cells. One critical selection factor for the B cell to become a long-lived mature 
peripheral B cell is the BCR signaling. In humans around 75% of the early immature B cells 
in the bone marrow recognize autoantigens. This number is reduced to ∼40% when the cells 
are ready to leave the marrow, and in the pool of mature circulating B cells the percentage of 
autoreactive B cells is ∼20%. The first elimination of autoreactive B cells is during the central 
tolerance checkpoint and the second occurs outside the bone marrow and is called the 
peripheral tolerance checkpoint in the T2 stage. This checkpoint probably occurs when the 
BCR recognizes new autoantigens that are not present in the bone marrow and when B cell-
activating factor of the TNF family (BAFF) receptor (BAFFR) is expressed52,53. 
Two cytokines that have a profound impact on B cell survival and development are, BAFF 
and a proliferation-inducing ligand (APRIL), both members of the TNF family. BAFF and 
APRIL are both produced by stromal cells in the splenic red pulp and provide basic survival 
signals to B cells54. Even though stromal cells are capable of producing BAFF, this cytokine 
is primarily produced by follicular dendritic cells (FDCs) in the B cell follicles of the spleen 
and the lymph nodes, and can also be produced by other immune cells, such as macrophages, 
DCs and neutrophils55,56. Both APRIL and BAFF interact with the receptors transmembrane 
activator and calcium-modulator and cyclophilin ligand interactor (TACI) and B cell 
maturations antigen (BCMA), which are present on B cells and BAFF also interacts with the 
BAFF receptor57. BCMA expression is restricted to plasmablasts and plasma cells, and 
promotes the survival of long-lived plasma cells.  
To maintain the homeostasis of mature peripheral B cells at least two receptors, BAFFR and 
BCR, are required to signal. BAFF receptor signaling is required for all B cell populations 
after the T1 stage, except for memory B cells and B1 B cells. BAFF or BAFFR-deficient 
mice have a marked reduction in B2 B cells while the B1 B cell population in peritoneum 
stays unaffected58,59. Mice deficient in BAFF or BAFFR are able to form GCs efficiently, but 
they are not able to sustain the GC reaction60. Overexpression of BAFF leads to increased 
size of the B cell compartment and also survival of autoreactive clones, which would 
otherwise have been deleted in the periphery61. Similarly, patients with autoreactive B cells 
and autoimmune disorders have been correlated with increased serum titers of BAFF. 
Interestingly, autoreactive B cells that are induced by overexpression of BAFF do not require 
T cell help 62. 
There are two major driving forces for the B cell to become either a follicular B cell or a MZ 
B cell. First off is the signaling through the BCR. Strong BCR signaling favors a follicular B 
cell development through activation of the Btk pathway, and cells with weaker BCR 
signaling become MZ B cells. The second important factor for MZ B cell differentiation is 
Notch signaling63. B cells can only become MZ B cells if they receive signals from Notch. 
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The ligand for Notch2 is deltalike-1 (Dll-1), expressed by endothelial cells in the red pulp of 
the spleen64. Strong BCR signaling leads to activation of Btk, which inhibits Notch signaling 
and reduces the MZ B cell potential. On the other hand, weak BCR signaling leads to Notch2 
signaling which in turn activates the transcription factors Mastermind-like 1 (MAML1) and 
recombining binding protein suppressor of hairless (RBP-Jκ) both of which are essential for 
Notch signaling. MZ B cell development is defective in Notch2, Dll-1, MAML1 or RBP-Jκ-
deficient mice. Reduced expression of the transcription factor E2Α and increased expression 
of the opposing transcriptional factors inhibitor of DNA (Id2) and Id3 levels facilitates MZ B 
cell development and reduces follicular B cell development. Id2 and Id3 can diminish the 
function of E2A63. Recent data has provided a link between Notch signaling and Id2, since 
Notch signaling elevates the expression of Id2 in MZ B cells65.  
 
1.1.4 The spleen 
The spleen is the largest secondary lymphoid organ and the site of the adaptive immune 
response initiation. As described in the previous section one important function of the spleen 
is the peripheral development of B lymphocytes. The spleen can be subdivided into the red 
pulp, containing plenty of red blood cells, hence the name, and white pulp where the 
lymphocytes are located (Fig. 1). 
The red pulp is important for filtering the blood and holding numerous macrophages that 
phagocytose ageing erythrocytes and blood-borne pathogens. It also accommodates 
plasmablasts and plasma cells that have left the white pulp. Cells can leave the white pulp by 
upregulation of CXC motif chemokine receptor (CXCR) 4, the receptor for CXC motif 
chemokine ligand (CXCL) 12 that is expressed by stromal cells, macrophages, neutrophils 
and DCs in the red pulp66.  
 
 
Figure 1. B cell follicle with metallophilic 
macrophages and marginal zone B cells. 
Immunofluorescence of a wild type mouse spleen 
shows B220+ B cell follicles (blue), CD169+ 
metallophilic macrophages (green) and CD1d+ 
marginal zone B cells (red). The red pulp (RP), B cell 
follicle (FO), marginal zone (*), and T cell zone (T) 
are indicated.  
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The white pulp consists of DCs and lymphocytes, further subdivided in B cell follicles and T 
cell zones, also known as periarteriolar lymphoid sheath (PALS) (Fig. 1). For B cells to home 
to the follicles in lymphoid organs the CXCL1367, produced by FDCs and stromal cells, and 
its receptor CXCR5 are required68. T cells and DCs require the CC-chemokine ligand (CCL) 
19 and CCL21, produced by stromal cells, to get to the T cell zones69. The receptor for both 
CCL19 and CCL21 is CCR7, and is expressed by B cells, T cells and DCs, which all have 
impaired migration in CCR7-deficient mice70 (Fig. 2).  
In mice there is an area next to the white pulp, towards marginal zone, called the marginal 
sinus. The marginal sinus is the end of the smallest arterial branches in the spleen. The 
marginal zone and the marginal sinus form a boundary between the red and white pulp (Fig. 
2).  
The major conventional B cell population in the spleen is the follicular B cells that accounts 
for 80–90%, while the MZ B cells account for 5–10% of all B cells in an adult mouse. MZ B 
cells are strategically located in the interface between the circulation and the follicle to 
remove blood-borne pathogens. Blood, containing the lipid mediator sphingosine 1-
phosphate (S1P) flows throw the marginal zone of the spleen. S1P is the only known ligand 
for the S1P receptor 1 and 3 (S1P1 and S1P3, receptively). The S1P receptors are required for 
B cells to overcome the CXCL13 mediated attraction to the follicle and exit to the marginal 
zone. MZ B cells are able to transport antigens to FDCs by shuttling between the marginal 
zone and the follicle. The shuttling back and forth is regulated by a balanced expression of 
S1P1 and CXCR5. However, S1P1-deficient B cells are able to localize in the marginal zone 
of mice lacking CXCL13, the ligand for CXCR571,72. CXCR4 has long time been thought to 
be the exclusive receptor for CXCL12. Although recent publications have shown that 
CXCR7 can bind with high affinity to CXCL12 as well and that CXCR7 is upregulated on 
MZ B cells but not on follicular B cells. A block of CXCR7 leads to reduced number and 
disrupted architecture of MZ B cell. This implies a role of the chemokine receptor CXCR7 in 
B cell homing to the marginal zone73,74.  
 
1.1.4.1 Macrophages in the spleen 
In the marginal zone we also find MZ macrophages (MZM) that express PRRs such as 
specific intercellular adhesion molecule-3-grabbing nonintegrin-related 1 (SIGN-R1), 
scavenger receptor A (SR-A) and macrophage associated receptor with collagenous structure 
(MARCO) (Fig. 2). SIGN-R1 is a C-type lectin while SR-A and MARCO are both scavenger 
receptors. MZMs are important for removal of both blood-borne pathogens and of apoptotic 
cells from the circulation.  
Under the marginal sinus, towards the white pulp, is the location of the metallophilic 
macrophages expressing the adhesion molecule CD169 (sialoadhesin). Since it is extremely 
hard to remove one of the cell populations without influencing the other in experiments, the 
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specific contribution of MZM and the metallophilic macrophages in the clearance of 
apoptotic cells is still uncertain. Both cell subsets do express different sets of receptors 
recognizing apoptotic cells, which makes it possible that they have distinct functions in the 
removal of dying cells75 74. 
 
 
Figure 2. Schematic picture of the splenic white pulp with the marginal zone and the marginal sinus. Important 
receptors and ligands discussed in the text are highlighted. Illustration by Emelie Risberg. 
 
During the germinal center (GC) reaction a large number of B cells go into apoptosis because 
of failure in antigen recognition. The tingible body macrophages are located in the GC to 
remove all the B cells that go into apoptosis. It is important for the engulfment by the 
macrophages that the apoptotic cell express phosphatidylserine (PS). PS on the cell surface 
works as one of several “eat-me” signals, and is normally located cytosolic side of the plasma 
membrane. PS can be bound to tingible body macrophage by Tim-4 or by the soluble 
bridging molecules milk fat globule EGF factor 8 protein (MFGE8) and growth-arrest-
specific 6 (GAS6), which in turn can be recognized by the phagocyte receptors αvβ3-integrin 
or the tyrosine kinase Mer respectively expressed on the tingible body macrophages. Mer is 
expressed by red pulp macrophages and DCs but not on MZM or metallophilic macrophages 
while MFGE8 is only found on tingible body macrophages76.  
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There is a small population of macrophages also found in the T cell zone. These macrophages 
lack markers specific for MZM and the red pulp macrophages, and needs to be more 
investigated 75. 
The marginal zone is populated by three cell types, DCs, MZ B cells and MZMs. DCs can be 
located in the marginal zone temporarily, but leaves the marginal zone to the T cell zone after 
activation and antigen uptake75. There is close contact between the metallophilic 
macrophages, MZ B cells and the MZMs, and they influence each other. Several different 
mouse strains that lack B cell cells do also lack metallophilic macrophages and MZMs77,78. 
Mice lacking CD19, which is only expressed on B cells, have B cells in the periphery but lack 
MZ B cells79. These mice do also lack the MARCO+SIGN-R1+ MZM while the 
MARCO+SIGN-R1- cells are still present80,81. By depleting MARCO+ MZMs with 
macrophage-depleting liposomes there is a specific reduction of MZ B cells as well. 
However, op/op mice are deficient in metallophilic macrophages while the MARCO+SIGN-
R1- and MZ B cell populations are still present81,82. All together we can conclude that to form 
a proper splenic cell organization the marginal zone cells need to collaborate and influence 
each other.  
The white pulp is restricted for lymphocytes and DCs, though APCs can enter for antigen 
presentation. There is no blood flow through the white pulp as in the red pulp and large 
molecules are unable to enter. Small molecules such as chemokines and small antigens are 
able to penetrate the white pulp by the conduit system. A core of collagen fibers and 
fibroblasts build up the conduit system, which can present transported and locally produced 
chemokines, CXCL13 in B cell follicle and CCL21 in the T cell zone83,84.  
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1.2 THE GERMINAL CENTER  
A germinal center (GC) is an antigen-driven structure within the white pulp of the spleen. In 
the GC-process cognate B cells with some affinity for the antigen is selected and high-affinity 
BCRs are generated by somatic hypermutation (SHM). The final product of the GC is B cells 
with high affinity for the antigen, which can differentiate into plasma cells or memory cells.  
 
1.2.1 TI and TD immune responses 
The division into thymus independent (TI) responses and thymus dependent (TD) responses 
depends on whether T cell help is required for antibody production or not. The TI response 
can be further subdivided in two groups depending on the provoking antigen. The TI type 1 
group of antigens includes molecules that can bind to the BCR or to the TLRs, exemplified 
by bacterial lipopolysaccharides (LPS). The TI type 2 group of antigens is characterized by 
the requirement of clustering and cross-linking of the BCR in order to initiate an immune 
response. The prime example of a TI type 2 group of antigens is the highly branched 
polysaccharide Ficoll. TI antigens induce extrafollicular antibody responses and in general do 
not promote formation of GCs or elicit any memory, even if the primary antibody response 
can last for a long time85-87. TD antigens are processed and presented on major 
histocompatibility complex (MHC) class II molecules for T cell help in secondary lymphoid 
organs. TD responses against antigens such as keyhole limpet hemocyanin (KLH) and sheep 
red blood cells (SRBC) give rise to high-affinity antibody producing cells and memory B 
cells, conferring long-lasting antibody titers in the serum of challenged individuals. The 
following sections will focus on TD antigen responses. 
 
1.2.2 The zones 
The GC can be divided into two zones, light and dark. They are clearly visual and 
distinguishable with conventional histology methods. The light zone contains many cell 
populations - DCs (mostly FDCs), B cells (both B cells active in the GC reaction and IgD+ B 
cells in transit), T cells (majority is CD4+) and tingible body macrophages that engulf the 
apoptotic B cells. The dark zone is denser and contains almost exclusively B cells (Fig. 3). 
Initiation of proliferation by GC B cells can occur in the light zone but it is only in the dark 
zone where the cells can complete the cell-cycle88,89.  
 
1.2.3 Follicular dendritic cells 
Follicular dendritic cells (FDCs) are important for production of affinity maturated B cells. 
A majority of the recent in vivo research in the GC field has been done in lymph nodes. This 
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is due to the lower optical obstacles in lymph nodes compared to the spleen, enabling the 
application of new technology such as intravital two-photon microscopy, which relies on the 
penetration of electromagnetic radiation through tissues. In the lymph node, subcapsular 
macrophages catch the antigen from the lymph and deliver it to the follicular B cells that are 
able to transport the antigen to FDCs90.  
The FDCs mature from vascular mural cells, which are cells with contractile function 
wrapped around the endothelial cells of small blood vessels. FDCs are radiation-resistant 
which has made the research about FDC development more difficult since donor cells do not 
repopulate in bone marrow chimeric mice due to the already occupied niche. During the 
development of lymph nodes, lymphoid tissue organizing cells are triggered by retinoic acid 
to produce CXCL13 that attracts lymphoid tissue inducer (LTi) cells. LTi cells interact with 
lymphoid tissue organizing cells and stromal cells through lymphotoxin (LT) and the LT 
receptor, which together promote lymphocyte and stromal cell accumulation83. LTs belong to 
the tumor necrosis factor (TNF) family, which also includes FasL and CD40L, important for 
B cells in GCs. For normal generation of FDC structure LTs and TNF produced by B cells 
are both required. However, for the maintenance of splenic architecture in adult mice, only 
LTs, and not TNF, are required. Mice deficient in LTα have no lymph nodes or Peyer’s 
patches and fail to form GCs in the spleen in response to injected SRBC. They also fail to 
form GCs to the other TD antigens (4-hydroxy-3-nitrophenyl) acetyl-ovalbumin (NP-OVA) 
and trinitrophenyl (TNP)-KLH91. Interestingly, dose-dependent affinity maturation towards 
NP-OVA is found in LTα-deficient mice. LTα-deficient mice injected with 1-5µg NP-OVA 
show a marked reduction of high-affinity antibodies compared to wild type mice. When 
instead injected with high dose (200µg) of the same antigen the response depending on SHM 
and high-affinity antibodies were detectable in both strains, but still no GC formation was 
detected in the LTα-deficient mice92. Blocking the LT-specific LTβ receptor in adult mice 
leads to severe reduction of B cell follicles, metallophilic macrophages, MZM and no GC 
formation after SRBC immunization93.  
FDCs produce CXCL13 that attracts B cells and TFH cells to the B cell follicle. As a positive 
feedback loop, CXCL13 makes B cells produce more LT. The FDC and B cell interaction is 
facilitated by expression of vascular cell adhesion molecule 1 (VCAM1) and intercellular 
adhesion molecule 1 (ICAM1) on the FDCs. The receptors for VCAM1 and ICAM1, very 
late antigen 4 (VLA-4) and lymphocyte function associated antigen 1 (LFA-1) are expressed 
on follicular and GC B cells, respectively94(Fig. 3). FDCs produce several cytokines 
important for B cell stimulation, such as BAFF and IL-695. IL-6 is known to regulate terminal 
B cell differentiation. Mice lacking FDCs with capacity to produce IL-6 have reduced GC 
formation and SHM frequency in GC B cells96.  
The FDCs can retain intact antigen for long periods and they work as a reservoir for antigen 
during the GC reaction97. The FDCs bind the antigen itself or as an immune complex (IC) 
with antibody and/or with complement, which they trap in recycling endosomal 
compartments, to protect the antigen from degradation98. FDCs with antigen preloaded in IC 
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are much more potent for B cell activation and antibody production rather than the free 
antigen99. APCs present antigen in the context of MHC molecules. The binding of IC requires 
the use of different receptors, for example complement receptors 1 and 2 (CR1 and CR2, or 
CD35 and CD21, respectively) and Fc receptor (FcγRIIB, CD32). FcγRIIB is an inhibitory, 
low-affinity Fc receptor. In B cells, cross-linkage of the BCR and the FcγRIIB leads to 
tyrosine phosphorylation of the immunoreceptor tyrosine-based inhibition motif (ITIM). This 
is followed by upregulation of SH2 domain-containing inositol phosphatase (SHIP) that 
blocks Ca2+ flux due to disassociation of Btk from the plasma membrane, resulting in 
inactivation of the B cell. FcγRIIB-deficient mice have a reduced capacity to capture IC100. 
Inability to secrete antibodies leads to lack of detectable ICs on FDCs after immunization 
with NP-conjugated TD antigens. By crossing mice lacking ability to secrete antibodies with 
transgenic mice with BCR specific for the hapten NP Hannum et al. showed that GC 
formation and clonal expansion of an antigen-specific B cell are formed without help from 
FDCs101. Mice with a specific deletion of FcγRIIB in B cells have increased antibody titers in 
general, but also autoreactive antibody clones are increased. This suggests that FcγRIIB has 
an important role in tolerance regulation both in mature B cells and in the GC response102. By 
expressing high levels of FcγRIIB on the FDCs’ membrane, the risk of cross-linkage of BCR 
and FcγRIIB on the B cell is reduced103,104. The FDCs get the IC delivered by noncognate B 
cells, for example MZ B cells expressing CD21 and CD35 in the spleen. For retention of the 
antigen by FDCs the CD35 is essential and is expressed in high level on FDCs98,105. B cells 
predominantly express CD21 while FDCs express CD35 to a higher extent. Upon TD antigen 
challenge the FDCs require CD35 expression to be able to get a strong GC B cell response, 
while naïve CD35-deficient mice have normal B cell development and antibody titers106.  
 
1.2.4 T follicular helper cells 
Follicular T helper (TFH) cells are associated with GC B cells and are required for normal 
GC reaction. For the T helper cells to be able to reach the B cells to initiate a GC formation 
they upregulate CXCR5 and downregulate CCR7 after antigen recognition. To become TFH 
cells several molecules may play a role: Bcl-6, inducible T-cell costimulator (ICOS) and 
CD28107. As for GC B cells, both the receptors CXCR5 and S1P2 are important for TFH cells 
to localize in the GC108-110. The surface markers CD4+CD44+CD62L-CXCR5+PD1+ define 
TFH cells. Activated T cells such as the TFH cells express CD40L that interacts with CD40 on 
the surface of GC B cells. A block in this interaction abrogates the GC reaction111. CD40-
CD40L interaction is also important for isotype switching of B cells112. CD40 supports the 
early GC formation while expansion of dark zone B cells occurs in the absence of CD40 
signaling in B cells113. Two important interleukins for the GC response produced by TFH are 
IL-21 and IL-4 (Fig. 3). IL-21 is important for TFH differentiation and GC B cells. IL-21 
influences the GC B cells to express Bcl-6 and it also promote B lymphocyte-induced 
maturation protein (Blimp-1) expression and plasma cell formation. These very separated 
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functions make IL-21 important in both follicular and extrafollicular responses114. The 
contact between a TFH cell and a GC B cell is short-lived, even if the MHC class II molecules 
present a high level of cognate peptide. The cell-cell contact increases a transient Ca2+ flux in 
the TFH cell that is associated with expression of IL-4 and IL-21, which leads to an advantage 
for high-affinity B cells107,115,116. When ICOS+ TFH cells interact with B cells expressing 
ICOSL, the TFH cells produce IL-4. ICOSL-deficient mice have a normal GC formation but 
impaired selection of high-affinity B cells117. SLAM-associated protein (SAP) expression by 
TFH cells is important for stable T-B cell interaction. SAP interacts with the intracellular tail 
of membrane bound signaling lymphocytic activation molecule (SLAM) family members 
important for several different immunomodulatory functions such as adhesion and 
costimulation118. SAP-deficiency leads to reduced GC, plasma cell and memory B cell 
formation while extrafollicular responses are intact119. GC B cells with high amount of 
peptide-MHC class II presented to the cognate TFH cells have also more cell divisions and 
higher affinity maturation compared to GC B cells with less antigen on the surface120. In the 
initial T and B cell interaction at the T-B cell boarder, the T cell follows one B cell as a 
conjugate. These T-B cell conjugates can last up to 60 minutes while interaction between TFH 
cells and B cells in GCs are short and transient116,121. The TFH cells continue to another target 
GC B cell after the transient interaction116. GC B cells are clonally expanding within one GC, 
while TFH cells are able to leave a GC and emigrate to a neighboring GC. In the next GC the 
newly migrated TFH cells are able to participate in selection of GC B cells with high peptide-
MHC class II titers122. There are two limiting factors, in combination, for GC B cell 
expansion, first the antigen-specificity of the BCR and second the help from the TFH cells. B 
cells have to recognize and compete with other B cells for the soluble antigen or antigen 
presented on FDCs and get stimulation from TFH cells. If the TFH cells are able to invade 
ongoing GC reactions and interact with preexisting GC B cells for selection the specificity of 
the TCR may be polyreactive and not selecting only one GC B cell clone for expansion.  
 
1.2.5 B cells 
GC B cells can be identified by expression of the death receptor CD95 (Fas), n-
glycolylneuraminic acid (the ligand of antibody GL-7) and binding to peanut agglutinin 
(PNA). These cells are one of the fastest proliferating cell types known, and have an 
estimated cell-cycle time between 6-12 hours88,89. When B cells in the follicle gets activated 
by antigens they upregulate CCR7 for migration towards the ligands CCL19 and CCL21 
expressed in the T cell zone121. CCR7-deficient B cells gets to the B cell follicle but have a 
reduced capacity to migrate to the T cell zone70. For B cells to act normal and localize in the 
GC, regulation of two chemotactic G protein–coupled receptors, S1P2 and Epstein-Barr virus 
induced gene 2 (Ebi2) is important. S1P2 is important for GC homeostasis. GC B cells have a 
higher expression of S1P2 than follicular B cells. Deletion of S1P2 leads to uncontrolled 
growth of GCs and diffuse large B cell lymphoma with GC origin123,124. GC B cells 
downregulate Ebi2 after activation and migrate towards the center of the follicle where the 
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FDCs are located. Ebi2-deficient B cells localize in the middle of the follicle without 
activation. In Ebi2-deficient mice migration of plasmablasts towards the extrafollicular foci 
are lost and the early antibody production is reduced125-127. Upregulation of Ebi2 make the 
activated B cells move to the outer part of the follicle and to extrafollicular areas where the 
Ebi2 ligand, 7α,25-dihydroxycholesterol is increased128.  
 
 
Figure 3: Schematic picture of the germinal center. Important receptors and ligands discussed in the text are 
highlighted. Illustration by Emelie Risberg. 
 
Even if the light zone and the dark zone themselves are markedly different it is difficult to 
distinguish the B cells from the zones from each other by only looking at their morphology. 
In the splenic GCs the light zone is strategically placed towards the marginal sinus where the 
antigens enter whereas the dark zone is closer to the T cell zone (Fig. 2). The classical model 
of a GC reaction is that the B cells, centroblasts, proliferate vigorously and move from the 
dark zone to the light zone, become centrocytes which are less active and get selected for 
their antigen recognition129. New research has strengthen this theory but also added that the B 
cells can migrate in between the zones, with a net movement favoring from dark zone to light 
zone migration. During a 6 hours time lapse 50% of the dark zone B cells migrate to the light 
zone, while only 10% returns to the dark zone130,131. For the migration to occur chemokines 
and their receptors are needed. The FDCs covers a big area of the light zone, producing 
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CXCL13, which attracts B cells expressing the CXCR5 receptor. Both the chemokine and the 
receptor are necessary for normal accumulation in the light zone. For B cells to migrate to the 
dark zone CXCR4 expression is required and its ligand, CXCL12, potentially produced by 
local stromal cells in the dark zone. B cells in the dark zone have increased CXCR4 
expression compared to B cells in the light zone. In contrast there is no difference of CXCR5 
expression on B cells in the different GC compartments132,133. To be able to differentiate light 
zone B cells from dark zone B cells in mice Victora and colleagues identified the activation 
markers CD83, CD86 and CXCR4. CD83 or CD86 in combination with CXCR4 can separate 
light zone and dark zone B cells from each other, respectively130 (Fig. 3). In 2012 the same 
research group defined that the same markers can be used to detect GC B cell polarization in 
human tonsils 134. CXCR5-deficient mice have a severely impaired splenic architecture with 
lack of B cell follicles; instead the B cells accumulate close to the marginal sinus. After 
immunization with TD antigen GC-like structures are formed in close relation to the FDCs in 
the T cell zone in CXCR5-deficient mice. Even if the structures have no light zone/dark zone 
polarization the B cells go thorough high-affinity maturation. This shows that SHM can occur 
independently of GC polarization135. SHM in B cells can occur extrafollicular without CD40 
signaling for example after immunization with TI antigen, but the SHM rate is not as high as 
after TD antigen immunization136. In contrast to CXCR5-deficiency, B cells lacking the 
guanine exchange factor (GEF) dedicator of cytokinesis 8 (DOCK8) have formation of GCs 
at the correct location, but fail to produce B cells with high affinity for the antigen. DOCK8-
deficient B cells have impaired recruitment of ICAM1 to the BCR-associated immunological 
synapse. Even if no other BCR signaling related aspects are found altered, the DOCK8-
deficient B cells are unable to sustain GCs, similar to BAFF/BAFFR-deficient mice, and get 
high-affinity mutations137.  
 
1.2.5.1 Bcl-6 in B cells 
The transcription factor B-cell lymphoma 6 (Bcl-6) works as a transcriptional repressor. Mice 
lacking Bcl-6 are not able to form GCs or high-affinity plasma cells. Bcl-6 works in several 
complex ways to maintain GC phenotype of the B cells. Bcl-6 represses Ebi2 expression to 
localize the activated B cell in the follicle125. GC B cells are highly susceptible DNA damage 
by AID, which is required for SHM. To let the GC B cells tolerate this, Bcl-6 represses 
factors such as the cell-cycle controlling p5389,138. Bcl-6 keeps the GC B cell in a 
proapoptotic state by repressing the antiapoptotic protein Bcl-2139. Bcl-2 transgenic mice that 
have a block in cell death have increased titers of high-affinity memory B cells, while leaving 
the plasma cell number unchanged140. Blimp-1 is expressed mainly in plasma cells141, and its 
expression is regulated by Bcl-6 leading to no plasma cell formation as long as Bcl-6 is 
activated142,143. 
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1.2.5.2 AID, CSR and SHM  
In 1958 clonal selection was revealed by studying single cells and their incapacity to produce 
antibodies with specificities to more than one epitope144. This clonal selection occurs in the 
GC reaction via somatic hypermutations (SMHs) in the V(D)J region of the BCR. During B 
cell development, RAG-dependent V(D)J recombination expands the possible binding 
specificities for antigens of the BCR (Fig. 4). To be able to increase the affinity for specific 
antigens additionally the BCR goes through SHM. The area on the BCR with antigen 
recognition, the antigen-binding fragment (Fab), includes three regions with most antigen 
contact, the complementarity-determining regions (CDRs). These regions are also the once 
with highest frequency of mutations145(Fig. 4).  
The class of the BCR/antibody is defined by the IgH chain’s constant region (Fc). The 
different isotypes an immunoglobulin can be is IgD, IgM, IgG, IgA and IgE. Between the 
constant regions for the different heavy chains are switch (S) regions located. The class 
switch recombination (CSR) occurs between these S regions and the DNA between these 
regions is cut out as an extrachromosomal DNA switch circle. Activation-induced cytidine 
deaminase (AID), deaminates cytosines in both the donor and acceptor S regions, which 
induces a double break in the DNA (Fig. 4).  
During CSR the Fab regions of the immunoglobulin remains the same. Depending of what 
kind of stimuli the B cell receives different isoforms are produced. CD40 and TLR4 signaling 
are crucial for murine B cells to undergo CSR. LPS, the ligand for TLR4, skews the 
switching to a TI antigen response and production of IgG2b and IgG3. Stimulation with both 
IL-4 and CD40 or LPS induce IgG1 and IgE, and CD40 or LPS with interferon-γ (IFNγ) and 
transforming growth factor-β (TGFβ) make the B cells switch to IgG2a and IgA 
respectively112,146,147. CD40- or CD40L-deficiency leads to hyper IgM (HIGM) syndrome 
with marked reduction of switched isoforms148.  
The key enzyme for both CSR and SHM is AID. AID deaminates cytidine residues, both in 
V(D)J and switch regions of the immunoglobulin gene. The deamination of DNA specific for 
GC B cells changes deoxycytidine (C) into deoxyuridine (U) and transforms C:G pairs into 
U:G mismatch149. The deoxyuridines are removed by uracil DNA glycosylase (UNG) leading 
to single-strand breaks (SSBs). Since it has to be a double-strand break (DSB) for CSR to 
occur, it could either be two SSBs with close proximity on opposite DNA strands that forms 
the DSB naturally or during the mismatch repair of DNA the SSB is converted to DSB150. 
Interestingly, Bcl-6-deficient mice have a great reduction of AID and UNG expression. It 
might even be that Bcl-6 directly regulates UNG by being able to bind to the UNG locus143. 
Bcl-6-deficient mice do not form GCs and AID-deficient B cells have large spontaneous GC 
formation in spleen, lymph nodes and payer’s patches. After stimulation with TI antigen LPS 
in vitro AID-deficient B cells are unable to undergo CSR. CSR and SHM is also lacking after 
TD antigen immunization in AID-deficient mice151. 
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Figure 4. Antibody gene diversification. Schematic representation of the diversification processes of the IgH 
chain of the BCR locus. (i) The RAG-dependent V(D)J recombination occur in the bone marrow in immature B 
cells and is followed up in the spleen in GC B cells with (ii) the AID dependent class switch recombination and 
somatic hypermutation. (iii) The peaks represent highly mutated areas that differ from the germline sequence. 
The complementarity-determining regions (CDRs) are the areas with the highest amount of SHM in the IgH 
gene145 (from Di Noia, J.M. & Neuberger, M.S. Annual review of biochemistry 76, 1-22 (2007)). 
 
Although AID has its function in the nucleus, the biggest proportion of the AID protein is 
found in the cytoplasm. Since AID induces mutation in a million-fold higher rate than normal 
mutations, nuclear localization can lead to mutations in oncogenes, even if the AID off-target 
mutation rate is restricted152,153. The C-terminal portion of the protein is absolutely required 
for CSR, and mutations in this region lead to absence of CSR but SHM can still occur154. 
There are several mutations in the AID gene leading to HIGM. There is one mutation that is 
frequently detected in HIGM patients in amino acid position 112, leading to an arginine 
substitution to either histidine or cysteine145. This mutation in position 112, is the 
corresponding mutation in humans that we found in mice presented in paper IV. 
 
1.2.5.3 Memory B cells and plasma cells 
B cells that have interacted with cognate T cells can either decide to stay in the follicle and 
participate in the GC reaction, or they leave towards the marginal zone and become short-
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lived plasma cells in the extrafollicular foci. These plasma cells express the transcription 
factors Blimp-1 and X-box binding protein 1 (XBP-1), but lack SHM and high affinity for the 
antigen. Compared to B cells in GC reaction, Ebi2 is important for B cells that are involved in 
the extrafollicular response155. Except for extrafollicular responses, memory B cells and long-
lived plasma cells come from the GC reaction. One important difference between the two cell 
types it that memory B cells keep their BCR on the cell surface while plasma cells 
downregulate their BCR to become high producers of secreted antibodies. Compared to many 
other mature B cells, the memory B cells do not require BAFF or cognate BCR stimulation 
for their survival. Memory B cells can switch away from their initial recognition for the 
antigen, which makes them resting and not dependent on antigen recognition 156.  
In 1948, Astrid Fagraeus proposed that antibodies are produced by plasma cells and the B cell 
stages before becoming plasma cells were called immature plasma cells157. Now we know 
that the plasma cell fate is determined in the GC B cells. Plasma cells downregulate CCR7 
and CXCR5 and upregulates CXCR4 to be able to leave the follicle. Stromal cells in the bone 
marrow express CXCL12, which makes the CXCR4+ plasma cells home to the marrow158. 
Plasma cells in the bone marrow have gone through SHM and have high-affinity maturation, 
compared to memory B cells in the spleen with lower affinity for the antigen159.  
The master regulator of plasma cell differentiation is the transcription factor Blimp-1. 
Cytokines such as IL-2 and IL-5 are important inducers of Blimp-1 upregulation141. Blimp-1 
represses genes that are important for cell proliferation, such as the proto-oncogene c-Myc 
and Bcl-6, leading to cell-cycle arrest and terminal differentiation of the B cells160-162. The 
transcription factor Pax5 that is important for B cell commitment in the bone marrow might 
also have an important role in plasma cell formation. Pax5-deficient mature B cells have 
downregulated Bcl-6 and upregulated Blimp-1 and XBP-1 expression, which could indicate 
that Pax5 inhibits plasma cell formation163. Pax5 activates Bach2, which supports 
proliferation and CSR by repressing Blimp-1. Another challenging multifunctional 
transcriptional regulator upregulated by Pax5 is interferon regulatory factor (IRF) 4. IRF4 is 
required for GC formation, CSR and also for plasma cell formation, most probably in a dose 
dependent manner164. Systemic lupus erythematosus (SLE) patients have elevated plasma cell 
titers and also increased Blimp-1 expression165. Lupus prone mice, MRL-Fas(lpr), one mouse 
model for SLE, have increased Blimp-1 expression in peripheral blood and silencing of 
Blimp-1 lead to reduced anti-DNA antibodies166. 
Even if plasma cells have the intracellular machinery for antigen presentation and they 
express MHC class II and costimulatory molecules they are not able to induce activity of TFH 
cells. This regulation of response is thought to be a negative feedback loop to control ongoing 
B cell immunity to both foreign and autoantigens167. Preexisting antibodies compete with 
new GC B cells for binding to the antigen on FDCs and thereby increasing the selectivity for 
new high-affinity B cells 168. Next, I will present how aberration in the cytoskeletal proteins 
such as WASp, N-WASp and Cdc42 in B cells may have impact on GC responses and the 
immune system.  
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1.3 WISKOTT-ALDRICH SYNDROME  
Wiskott-Aldrich syndrome (WAS) is a rare potentially life-threatening X-linked primary 
immunodeficiency. WAS is characterized by a clinical triad of thrombocytopenia, eczema 
and immunodeficiency. The frequency of WAS is 1-10 per million males. Without treatment 
the outcome is poor, with a median survival of 15 years169. Since the first bone marrow 
transplantation made more than 40 years ago the outcome has become better and better. The 
only way to cure WAS is by hematopoietic stem cell transplantation or gene therapy, 
currently in clinical trial170. Up to 70% of WAS patients develop autoimmunity171,172.  
The protein causing WAS was identified 1994, and was named Wiskott-Aldrich syndrome 
protein (WASp)173. Cells from WAS patients and WASp-deficient mice show reduced 
cytolytic, phagocytic and antigen presenting functions, together with reduced antibody 
responses upon foreign antigen challenge174. WAS has been consider a T cell disorder, with 
only primary defects in T cells leading to secondary effects on other cell types175. In this part 
of the introduction I have focused on the role of WASp in B cells, since we know today that 
all hematopoietic cells have intrinsic dysfunctions in the absence of WASp.  
 
1.3.1 WASp family members in B cells 
The Wiskott-Aldrich syndrome protein (WASp) is an actin polymerizing protein 
belonging to WASp protein family. The WASp family of proteins includes eight proteins 
where neural WASp (N-WASp) is the most related protein to WASp. N-WASp is 
homologous to WASp, with 72% homology on the amino acid level, leading to 80% identity 
of the functional domains176. WASp expression is restricted to hematopoietic cells, while N-
WASp is ubiquitously expressed, leading to that N-WASp-deficiency is embryonic lethal177. 
WASp is a 502 amino acid protein and similar to N-WASp have five functional domains: the 
WASp homology 1 (WH1) domain, a basic region, a GTPase-binding domain (GBD), a 
polyproline-rich region and the C-terminal VCA domain (Fig. 5). The WH1 domain binds the 
WASp-interacting protein (WIP), which stabilizes the WASp protein and the GDB binds the 
RhoGTPase Cdc42 which activates WASp and N-WASp178,179. The conserved C-terminal 
region, verprolin homology (V, or WH2 motif), cofilin homology (C, or central) and acidic 
(A), build up the VCA domain. The V domain binds the actin monomers, while the A 
domain binds the actin-related protein 2 and 3 (Arp2/3) complex essential for the actin 
polymerization and the C domain has binding capacity to both the actin monomers and the 
Arp2/3 complex (reviewed in 178,180) (Fig. 5).  
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Figure 5. Wiskott-Aldrich syndrome protein (WASp) gets activated and opens up from the auto-inhibited 
conformation when the GTPase Cdc42 binds to the GTPase binding domain (GBD). The Arp2/3 complex binds 
to the VCA domain and monomeric actin becomes polymerized actin178 (from Thrasher, A.J. & Burns, S.O. 
Nature reviews. Immunology 10, 182-192 (2010)). 
 
1.3.2 WASp and N-WASp 
WAS patients have normal IgG titer in blood, while there is a decrease of IgM and increase 
of IgA and IgE titers181. WASp patients and WASp-deficient mice have similar defects in 
populating the splenic marginal zone174,182-184. As described above, there are some crucial 
steps for MZ B cell development. Btk activation upon antigen binding to the BCR is required 
for phosphorylation of WASp. Btk activates a GEF for the cell division control protein 42 
(Cdc42), which activates WASp that leads to actin polymerization and spreading. In contrast, 
by letting SHIP-1 suppress Btk activation, WASp activation is inhibited promoting 
contraction of the B cell. SHIP-1-deficient B cells have increased accumulation of 
polymerized actin and WASp phosphorylation in a Btk-dependent manner, leading to cell 
spreading185. Interestingly, N-WASp phosphorylation is increased, rather than decreased as 
for WASp, in Btk-deficient B cells. The opposite relation occurs in SHIP-1-deficeint B cells, 
where N-WASp is decreased while WASp is increased. This suggests that WASp and N-
WASP activation have different activation pathways and may counteract each other during 
specific conditions186.  
Until today, only two papers are published on Cdc42 in B cells187,188. The data from these two 
publications will be analyzed and compared to our findings in paper III in the section 
”Present study”. Similar to DOCK8-deficient mice, WASp-deficient mice have reduced 
ability to form immune synapses upon BCR signaling and ICAM1 stimulation183. MZ B cells 
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upregulate LFA-1 and interaction with ICAM1 mediates B cell adhesion, which is important 
for MZ B cell localization 189. The other important factor for MZ B cell development is Notch 
signaling. WKO B cells have reduced expression of one of the target genes (Hes1) in Notch-
signaling. In contrast, in bone marrow chimeric mice where only B cells lack WASp there is 
no difference in Hes1 expression, indicating that the reduced MZ B cell numbers are not 
because of defect Notch-signaling183.  
Mature lymphoid cells expressing WASp have a selective advantage over WASp-deficient 
cells in both human and mice182,183. This positive selection of WASp expression cells is not 
found in the myeloid compartment190. The locomotion capacity is reduced in WASp-deficient 
DCs, macrophages, T cells and B cells191-194. T cells deficient in both WASp and N-WASp 
have a more severe phenotype than WASp-deficient T cells. The double-deficient T cells 
show marked block in development resulting in reduced T cell number in the periphery, and 
the surviving cells have migratory defects towards CXCL12 and CCL19195. This finding in T 
cells was one reason that made us interested in investigating the role of WASp and N-WASp 
in B cells, resulting in paper I and II. If there are defects in functional migration capacity of 
cells, the interaction and stimuli between cells will lead to secondary defects in the target 
cells. Westerberg et al. showed 2008 that WASp-deficient MZ B cells have reduced 
migration capacity towards S1P as well as reduced S1P1 expression in MZP-T2 population 
and reduced S1P3 expression in the MZ B cell population, resulting in reduced homing 
capacity to the marginal zone182.  
 
1.3.3 The redundant function of actin regulatory proteins 
WASp and N-WASp reside in an auto-inhibited conformation in resting cells, and the 
conformation opens up upon extracellular stimuli, such as via the BCR. When Cdc42, binds 
to the GBD on WASp and N-WASp, the VCA domain is released from the GBD and the 
basic domain, located next to the GBD (Fig. 5). Cdc42 is a guanine nucleotide-binding 
protein that gets activated by binding of GTP. The switch from GDP to GTP is facilitated by 
GEFs, such as DOCK8. Cdc42 is within the small RhoGTPase family, together with 22 
other RhoGTPases196. Ras-related C3 botulinum toxin substrate 1 (Rac1) and Rac2 are two 
other small RhoGTPases important for B cell development. Rac2-deficiency leads to a loss of 
B1 B cells and MZ B cells, while Rac1-deficient mice have no altered B cell phenotype. Mice 
with both Rac1 and Rac2 deleted have a more severe phenotype with a B cell developmental 
block already in transitional B cells since both Rac1 and Rac2 are important for transduction 
of BAFFR signals197. Rac can be activated, as Cdc42, by DOCK8. Both Rac and Cdc42 can 
be activated by other GEFs as well, such as VAV1-3. Mice deficient in VAV1 has slightly 
reduced B1 B cell numbers, while other B cells develop normally. VAV1 and VAV2-
deficient mice have reduced numbers of both follicular and MZ B cells, and mice lacking all 
three, VAV1-3, have an even worse phenotype (described in a review by Tybulewicz et 
al.)196. The effector protein of Rac is WAVE, which also belongs to the WASp family of 
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proteins. WAVE and WASp/N-WASp induce different kind of protrusions of the plasma 
membrane, lamellipodia and filopodia structures, respectively. Lamellipodium is larger 
protrusions filled with polymerized actin, while filopodium are thinner and protrudes from 
the cell body or from the lamellipodium198. Activation of Cdc42 and Rac1 induce filopodia 
and lamellipodia, respectively, in B cells194. Even if the different RhoGTPases and effector 
proteins give rise to different actin containing structures, it is the MZ B cells that are first and 
most affected when actin-regulating proteins are deleted. The redundancy found in Rac1 and 
Rac2 and in VAV-family members is relevant to the redundant function of WASp and N-
WASp we see in paper II, and might also influence the results in paper I and paper III.  
 
1.3.4 WASp and autoimmunity 
By studying autoimmunity in WASp-deficient mice the knowledge of autoimmunity in 
primary immunodeficiency has increased. Up to 70% of WAS patients suffer from 
autoimmune disorders such as antibody-mediated cytopenia, arthritis, skin vasculitis, 
glomerulonephritis and inflammatory bowel disease172,178. Older WASp-deficient mice 
develop autoimmune features such as colitis, anti-nuclear, anti-dsDNA and anti-platelet 
antibodies181,190,199-201. Since all WASp deficient lymphocytes are defect, both T and B cells 
have a role in autoimmunity in WAS. T regulatory (Treg) cells are important for immune 
suppression, and disruption of functional Treg cells is a primary cause of autoimmune 
diseases202. Both WAS patients and WASp deficient mice have reduced Treg cell suppressive 
function which could explain the risk of development of autoimmunity190. Treg cells 
expressing WASp have a selective advantage, resulting in normal Treg cell population in 
female WASp heterozygous mice. Interestingly, these mice have increased autoreactive 
antibodies compared to wild type mice even if Treg cells are normal, suggesting a cell-intrinsic 
dysfunction in WASp-deficient B cells199. Two recent publications have investigated the role 
of WASp in B cells in breaking self-tolerance and autoimmunity in a setting of normal T-cell 
function. One study uses bone marrow chimerice mice to have expression of WASp in all 
cells except B cells, while the other study uses gene targeted conditional knock out 
mice199,203. The following section is a summary of the two studies.  
Mice with conditional WASp-deletion in B cells are in many aspects similar to complete 
WASp-deficient mice, presenting an intrinsic B cell dysfunction in WASp-deficient mice. 
WASp-deficient follicular and GC B cells are hyperproliferative and hyperresponsive to anti-
IgM and TLR stimulation. When hyperresponsive WASp-deficient B cells get the sufficient 
help from wild type cells, e.g. DCs and T cells, the phenotype is more severe than if all cells 
lack WASp. The B cell conditional WASp-deficient mice have reduced marginal zone, 
reduced humoral response to TI antigens, increased IgM titers in serum and autoantibody 
production similar to the complete WASp-deficient mice. In addition, the B cell conditional 
WASp-deficient mice have also spontaneous GC formation and renal histopathology 
associated with autoantibodies199,203.  
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2 THE PRESENT STUDY 
2.1 AIM 
The general aim of the present study was to elucidate the role of primary immunodeficiency-
associated proteins in humoral response to both foreign and autoantigens.  
 
The specific aim for each individual paper was: 
Paper I – To clarify the specific role of actin-regulating proteins WASp and N-WASp in B 
cell activation to foreign antigens and autoantigens. 
 
Paper II – To elucidate the unique and redundant activity of WASp and N-WASp for B cell 
development and function. 
 
Paper III – To identify the specific role of the RhoGTPase Cdc42 for B cell activation and 
the humoral response. 
 
Paper IV – To characterize the recessive and spontaneous AID mutation causing Hyper IgM 
syndrome in mice.
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2.2 MATERIAL AND METHODS 
This section explains two important methods used in this thesis. A more detailed description 
of all methods used can be found in the individual papers.  
 
2.2.1 Mice and the Cre/loxP system 
In papers I-III, the genes N-WASp and Cdc42 were deleted conditionally from B cells by 
using the Cre/loxP system. The advantage of this system is the ability to inactivate genes in 
specific cells and/or at a specific time, depending on under what promoter the Cre 
recombinase is located. By mating Cre-expressing transgenic mice with mice having the gene 
of interest flanked with recombinase recognition sites, loxP sites “floxed”, the Cre 
recombinase can cut out the region between the loxP sites204. By using Cre-ERT2 mice, as in 
Paper III, the gene inactivation can occur during controlled time points by giving the mice 
tamoxifen by gavage. Tamoxifen is an antagonist for the estrogen receptor ERT2 normally 
located in the cytoplasm. Binding of tamoxifen to Cre-ERT2 makes the complex relocate to 
the nucleus for recombination. Important to think about when using Cre deletion of genes is 
that the gene is normally expressed until the promoter where Cre is located under gets 
activated. Since the protein of interest is expressed at normal levels before the Cre 
recombinase is activated it is important to take the half-life of the protein into consideration, 
and measure the deletion of the protein in different maturation stages of the cells. When Cre 
is located under the CD19 promoter it is know that the Cre recombinase deletes the floxed 
target gene in 75–80% in bone marrow-derived pre-B cells and 90–95% in splenic B cells205. 
In paper I and II we have used heterozygote CD19+/Cre which contains one functional CD19 
allele and is phenotypically normal. The following mice were heterozygous for Cre – paper I 
and II; N-WASpfl/flCD19+/Cre, paper III; Cdc42fl/flCD23+/Cre and Cdc42fl/flMb1+/Cre-ERT2.  
 
2.2.2 NP-KLH as antigen 
The advantage of using NP-KLH as antigen is the well-characterized clonal expansion of B 
cells after immunization, without usage of transgenic mice. NP-KLH gives rise to high-
affinity antibodies with specificity for NP. More than 50% of the NP-specific B cells express 
the IgH VH1-186.2 paired normally with a λ light chain206,207. The specific mutation in VH1-
186.2 induced in high-affinity BCRs/antibodies are in amino acid position 33, a tryptophan to 
a leucine exchange (W33L) and the antibody with this specific mutation was from the 
beginning named 3B44. Antibodies can have high affinity to NP, for example 3B62, but in 
those cases no specific high affinity mutation have been found208. Amino acid 33 is within the 
CDR1. We have determined the high-affinity mutation rate in wild type, WKO and cDKO 
mice in paper I, and in AIDR112H mice in paper IV, by sequencing the CDRs. When looking 
for different mutations, alterations from the germline sequence are mostly found in the CDR3 
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region. This region covers the junctions between the V, (D), and J segments thus becoming 
the most variable part. In short the procedure is as follow; a polymerase chain reaction (PCR) 
using a forward primer binding to the specific VH1-186.2 and a reverse primer binding to the 
constant region of interest, for us Cµ and Cγ1 in paper I and paper IV. The PCR products 
were cloned into TOPO TA for amplification and the products were sequenced and compared 
to the results of the corresponding germline sequence.  
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2.3 RESULTS AND DISCUSSION 
2.3.1 The discovery of a new spontaneous AID mutation in mouse 
For the ease of discussion I will first discuss paper IV followed by papers I-III. 
In a separate project Lena Ström and Torkild Visnes, co-authors on paper IV, were 
investigating mice heterozygous for a gene-trap mutation in nipbl (Nipped-B like) NIPBL, is 
a protein complex important for loading the cohesin complex to the chromosomes209. We 
screened these mice for antibody titers and performed Ig-class switching experiments in vitro. 
We found that some of the control mice were incapable of producing class switched 
antibodies both in vivo and in vitro. After some investigations, this finding led to paper IV. 
The control mice, nipbl+/+, were littermate controls to nipbl +/- mice, which showed normal 
titers of switched antibodies.  
As described above, Minghui He examined the class switching capabilities in vitro using 
splenic B cells from nipbl+/- mice and as littermate control she used B cells from nipbl+/+ 
mice. I investigated total antibody titers in serum from the remaining mice in the same litter 
by enzyme-linked immunosorbent assay (ELISA). In one of the control mice our 
collaborators could not detect any CSR, while I found three additional mice without any 
detectable IgG but elevated titers of IgM antibodies in serum. These two experiments were 
the start of an interesting and fun parallel project during Minghui He’s and my graduate 
studies.  
We bred mice with no IgG antibody titers with each other hoping to obtain more mice with a 
similar phenotype. The offspring had no detectable IgG and relatively higher IgM antibody 
titers than wild type mice. Since the mice originated from an outbred strain (CD1), we 
backcrossed the mice to a C57Bl/6 background for further analysis. After one generation of 
backcrossing to C57Bl/6 background, the hyper-IgM (HIGM) phenotype was clearly 
detectable, and we could show that the phenotype was hereditary. The mice were screened by 
ELISA and categorized by the presence or absence if HIGM phenotype. We first thought of 
investigating the mRNA expression from genes that can cause HIGM syndrome, e.g. genes 
encoding for CD40, CD40L, AID or UNG210. Since we observed a defective antibody 
production by B cells in in vitro, we hypothesized that the defect was B cell intrinsic. We 
therefore excluded CD40L-deficiency. CD40 is needed to sustain GC reaction139 and since 
we detected spontaneous GC formation we also excluded CD40 from the list of potential 
missing proteins. The levels of aicda and ung mRNA in HIGM B cells were similar to that of 
wild type B cells. Next we sequenced cDNA coding for the different proteins, with aicda as a 
first candidate. Strikingly, we found a mutation in position 427, leading to a replacement of 
arginine to histidine in amino acid position 112 of the AID protein. The HIGM mouse was 
therefore given the name AIDR112H. This mutation is located in the linker region between the 
cytidine-deaminase motif and the apolipoprotein B mRNA-editing enzyme, catalytic 
polypeptide 1 (APOBEC1) – domain. This mutation has been found in several unrelated 
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HIGM patients but until now there has been no animal model replicating this genetic 
mutation of HIGM147,211. Next we immunized AIDR112H mice with NP-KLH, and found that 
no high-affinity B cells were formed, but some mutations in other positions could still be 
detected (data not shown).  
The behavior of the mutated protein we detected was similar to the wild type protein. 
AIDR112H protein was located in the nucleus and was able to bind to the switch regions 
required for CSR. This suggested that the AIDR112H mutation, which is located in between 
two important regions in the aicda gene, makes the protein catalytically inactive. One very 
interesting phenotype found in AID-deficient mice, and in our AIDR112H mice, is the 
spontaneous formation of GCs. In AID-deficient mice the sustained GC formation could be 
explained by reduced apoptosis detected in B cells lacking AID212. Interesting future projects 
include more molecular studies on AIDR112H B cells. It would be of outstanding interest to 
measure the amount of Bcl-6, Bcl-2, IRF4, Blimp-1 and other factors known to play a role in 
GC and plasma cell formations. How these factors regulate AID expression has been studied, 
but it is to my knowledge unknown if and how AID regulates the factors. Experiments with 
bone marrow chimeric mice with B cells lacking or expressing AID show that AID-deficient 
B cells have an advantage in occupying the GC212. By making chimeric mice with bone 
marrow from both AID-deficient mice and AIDR112H mice we could investigate if our 
AIDR112H protein would make the B cells behave more like a wild type B cells or as AID-
deficient B cells.  
Finally, I would like to speculate – how come a spontaneous mutation in AID is allowed to be 
inherited by mice with a mutation in nipbl? In all mice screened, the HIGM phenotype was 
found only in nipbl+/+ mice. Fewer mice with the genotype nipbl+/- were born compared to 
mice with the genotype nipbl+/+ and the AIDR112H mutation may be derived from the nipbl+/- 
mouse. If the AIDR112H mutation is derived from the nipbl+/- mouse it may be that it was just 
by chance that no nipbl+/- mouse had detectable HIGM phenotype. From where the AIDR112H 
mutation originates could be investigated more thoroughly. NIPBL is important for correct 
loading and function of cohesion, which is important for chromatid and gene regulation but 
also for DNA repair213. Could it be beneficial to lack functional AID if the nipbl protein is not 
functional? Yes! Likely, since NIPBL is important for DNA repair and AID is causing double 
strand breaks in DNA it is possible that nipbl +/- mice that also lack functional AID have a 
survival advantage. Deficiency in functional NIPBL causes the developmental disorder 
Cornelia de Lange syndrome (CdLS). Recurrent infections are a significant cause of mortality 
in CdLS, and 30% of the patients in one study had antibody-deficiency syndrome214. Could it 
be that the CdLS patients with antibody-deficiency syndrome actually have mutation in their 
AICDA gene? If AID mutation and/or dysfunction are partly the cause of the recurrent 
infections leading to mortality of the CdLS patients I think it would be of great interest to 
investigate AID expression and function, as well as potential mutations, in the patient’s B 
cells. One study from 2013 shows that B cells derived from CdLS patients have reduced 
sensitivity to DNA damage and reduced CSR215, which implies that AID expression might be 
altered in these B cells.  
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2.3.2 The role of Cdc42, WASp and/or N-WASp in murine B cells 
Wiskott-Aldrich syndrome (WAS) is considered a cell-trafficking disease in which all 
hematopoietic cells show decreased migratory, adhesive and receptor-mediated responses. 
Since Cdc42 is a RhoGTPase for WASp and N-WASp, we could speculate that similar 
phenotype should be detected in mice lacking Cdc42 or both WASp and N-WASp, together 
with a milder phenotype in WASp-deficient mice. In the following results and discussion part 
I have compared the findings in these mice. We hypothesize that Cdc42, WASp and/or N-
WASp-deficiency leads to skewed responses due to intrinsic cell dysfunction but also altered 
cellular composition of the spleen, contributing to immunodeficiency and autoimmunity. To 
be able to address this question we have taken the approach to use animal models.  
During the course of this work some results from a similar study by Burbage et al. have been 
published regarding Cdc42-deficient B cells. There are similarities and differences between 
the two studies, and I will discuss the findings in relation to each other in the following 
sections.  
 
2.3.3 Nomenclature and mice used in paper I-III 
For the sake of simplicity I will begin with the description of the mouse strains used in 
papers I-III. The following abbreviations are used: WKO (WASp deleted in all cells, normal 
N-WASp), cNWKO (normal WASp, N-WASp deleted conditionally in B cells), cDKO 
(WKO mice with specific deletion of N-WASp in B cells) and Cdc42KO (Cdc42 deleted 
conditionally in B cells) (Fig. 6). In paper III we have used two different Cre-transgenic 
mice, Cdc42fl/flCD23+/Cre and Cdc42fl/flMb1+/Cre-ERT2 and which one used is stated for each 
experiment. In paper I and II a comparison between WKO and cDKO B cells demonstrates 
the intrinsic role of N-WASp. These mice were of mixed background (129Sv x C57Bl/6), 
following breeding of WKO mice on a 129Sv background, conditional N-WASP KO mice on 
a 129Sv background and CD19+/Cre mice on a C57Bl/6 background. Mice with a mixed 
genetic background (129Sv x C57Bl/6) have increased probability for expression of 
autoimmune disease216. We have not backcrossed the cDKO mice in paper I and II, to one 
pure background and this could have an potential effect on the autoimmunity we see in the 
naive mice, even if the controls are littermates.  
 
Figure 6. Explanation of mice used in paper I-III. 
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2.3.4 Alterations in splenic cell populations  
By flow cytometry, we found that the marginal zone precursor (MZP) and the MZ B cell 
populations were decreased in WKO and cDKO mice. cNWKO mice had normal MZP 
numbers while a cellular reduction of MZ B cells was detected by flow cytometry. This 
reduction was not distinguished by immunohistochemistry of spleens from cNWKO mice, 
where both MZB cells and MZMs appeared similar to those in wild type mice. MZ B cells 
from WKO mice have increased turnover rate183, which we also found in both WKO and 
cDKO mice in vivo, most likely compensating for the reduced cell number. There was no 
difference in cell death, measured in vitro, between the strains regardless of stimulation. In 
comparison to the normal numbers of T1 B cells in WKO and cDKO mice from paper II, the 
Cdc42fl/flCD23+/Cre mice in paper III had reduction in the populations transitional 2 (T2)-
MZP and MZ B cells, but an increase of T1 B cells. In contrast, Cdc42fl/flMb1+/Cre-ERT2 mice 
had reduced total B cell numbers including all naïve B cell populations, transitional and MZ 
B cells, in the spleen. This difference between the Cdc42fl/flCD23+/Cre and Cdc42fl/flMb1+/Cre-
ERT2 mice could be expected since CD23 is not expressed on T1 B cells, and is first expressed 
in T2 B cells28. Cdc42fl/flCD19+/Cre B cells also differ from WASp and N-WASp-deficient B 
cells in that they show significantly reduced proliferation and increased apoptosis in vitro187. 
In paper I we found a decrease in the T2 and T3 populations in WKO and cDKO mice 
compared to wild type mice. In wild type mice, B cells with autoreactive phenotype become 
anergic and classified as T3 B cells without further maturation as protection from 
autoimmunity. Several young lupus prone mouse strains have reduced T3 population, since 
the autoreactive B cells are not negatively selected for further maturation50,51. Since we see 
increased autoreactivity in our WKO and cDKO mice in Paper I, our results support 
previous data, that T3 B cells have increased self-reactivity. 
B cell positioning in the marginal zone is important for clearance of blood-borne pathogens. In 
experimental models, MZ B cells have been shown to use CD21/CD35 for capturing the TI 
antigen TNP-Ficoll and shuttle to the FDCs for antigen delivery71. In paper II we show that 
WKO mice (as previously published by Westerberg et al. 2008) and cDKO mice have 
reduced ability to capture and transport TNP-Ficoll, resulting in a reduction of the specific 
switched antibody response in both strains 7 days after injection compared to wild type mice.  
Excess of apoptotic cells is a major contributor to the development of autoantibodies and 
leads to a potential pool for autoantigens. Cells of the marginal zone are important for taking 
up apoptotic cells. It is known that WKO bone marrow derived macrophages show reduced 
and delayed clearance of apoptotic cells217. WKO mice have reduced MZMs and cDKO mice 
have reduction of both MZMs and metallophilic macrophages. However, cNWKO mice have 
normal macrophage composition in the spleen. The findings of reduced marginal zone 
cellularity and B cell function in paper II raised our interest in investigating the autoimmune 
milieu in the WASp and N-WASp-deficient mice, leading to paper I. We hypothesize that a 
decreased protective shield of the marginal zone together with intrinsic cell dysfunction leads 
to altered uptake, response and activation of B cells to autoantigens. To investigate the 
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localization of dying cells carboxyfluorescein succinimidyl ester (CFSE) labeled syngeneic 
apoptotic thymocytes were intravenously injected into the mice. As expected the CFSE 
labeled cells were localized in the marginal zone 30 minutes after injection in wild type mice. 
Even if WKO and cDKO mice show reduced cellularity in the marginal zone, the injected 
apoptotic cells were found located in the same area as in wild type mice. Since both 
macrophages and B cells in the marginal zone were reduced in WKO and cDKO mice, and 
the CFSE labeled apoptotic cells got captured in the marginal zone, we hypothesized that 
dendritic cells (DC, CD11c+) may be involved. Indeed, the CD11c+ population was markedly 
increased in both WKO and cDKO mice, located both in the marginal zone and in the T cell 
zone. A specific CD11c+CD8+ DC subset, able to capture and endocytose dying cells, is 
located in the marginal zone of mice. The subset is CD8+ and CD11c+ while CD205 
(DEC205) seems not important for capturing of apoptotic cells218. This makes the population 
specific since a big proportion of CD8+ DCs is CD205+. A potentially good marker for these 
marginal zone specific DCs could be CD207 (Langerin). CD207+CD8+ DCs express CD205 
depending on location in the spleen, analyzed by immunohistochemistry. CD207+ DCs in the 
T cell zone express CD205, while the CD207+ DCs in the marginal zone do not219. It would 
be interesting to verify what the increased CD11c+ population we see is in more detail by 
staining for CD8, CD205 and CD207. The cells could be a mixture of DCs both able and 
unable to capture apoptotic cells. Alternatively, they could be other cell types such as 
activated T cells220.   
 
2.3.5 Spreading, migration and homing capacity  
In paper II and III we measured the ability of IL-4 pretreated B cells in vitro to spread and to 
form long protrusions upon stimuli. Wild type and cNWKO B cells showed a high percentage 
of spreading while spreading was reduced in WKO, cDKO and Cdc42KO B cells. cDKO B 
cells had almost abolished capacity to spread and form short filopodia extensions. The 
filopodia extensions are important for cells to probe their environment, and both WASp and 
Cdc42-interacting protein 4 (CIP4) are important for their formation. CIP4 is an effector 
protein of Cdc42 and mediates WASp interaction with microtubules, in turn assembling the 
cytoskeleton221. CIP4 was absent in the protrusions of Cdc42KO B cells while it could be 
seen in the long protrusions of wild type B cells. Reduction of CIP4 or Cdc42-expression 
limits microtubule organizing center (MTOC) polarization, promoting immune synapse 
formation222,223. Cdc42fl/flCD19+/Cre B cells do not have reduced migration capacity towards 
CXCL12 or CXCL13187. In contrast, all WASp-deficient hematopoietic cells have reduced 
migration capacity, including WASp and N-WASp-deficient T cells 187,191-195. In paper II we 
show that B cells deficient in WASp and N-WASp have reduced ability to migrate towards 
CXCL12 in vitro.  
Since analysis of B cell numbers, architecture of the spleen as well as functional assays of B 
cells from cNWKO mice showed a phenotype similar to wild type mice, we decided not to 
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investigate these mice further in paper II. However, Dr Wenxia Song was interested in 
studying the role of N-WASp in BCR signaling and collaboration was set up between our 
groups. This collaboration led to the recently published finding that N-WASp is a critical 
negative regulator of BCR signaling186. This novel knowledge plays a role for our paper I as 
discussed below.  
Since we observed a reduction of spreading and migration towards chemokines in B cells 
deficient in WASp and N-WASp, we wanted to evaluate the homing capacity of splenic B 
cells from WKO and cDKO mice in vivo in paper II. Strikingly, both WKO and cDKO B 
cells had reduced homing capacity to lymphoid organs compared to wild type B cells. 
Furthermore, cDKO B cells had a more pronounced reduced capacity to home to the Peyer’s 
patches in the small intestine, both in competition with wild type and WKO B cells. Even if 
Cdc42fl/flCD19+/Cre B cells have normal migration capacity in vitro187, Cdc42fl/flMb1+/Cre-ERT2 
B cells had reduced homing ability in vivo. By injecting CFSE-labeled B cells intravenously, 
we showed in paper III that less Cdc42fl/flMb1+/Cre-ERT2 B cells localized to the spleen 
compared to wild type B cells. The decision to use both immunized donor and recipient mice 
was based on a previous publication by Westerberg and Severinson on WKO mice, where no 
homing of WKO B cells from unimmunized mice to the spleen was detected174. The result of 
reduced homing capacity of Cdc42fl/flMb1+/Cre-ERT2 B cells to the spleen in adoptively transfer 
experiments can be compared to data from experiment with hen egg lysozyme (HEL)-
specific Cdc42fl/flMb1+/Cre B cells by Burbage et al. Their HEL-specific B cells lacking Cdc42 
had similar migration to the draining lymph node as wild type HEL-specific B cells in HEL 
immunized mice. There are some technical differences between the homing experiments 
performed. First, the amount of transferred B cells might be different; we injected 
approximately 107 B cells per mouse while the amount of injected cells is not stated in the 
article from Burbage et al. If fewer cells are injected, the importance of homing capacity 
might be clearer. Second, the administration route of the antigen affects the organ to which 
injected cells home. We used intravenously injection of cells while their cells were 
intravenous injected but the antigen was administered in the footpad188. The location of the 
popliteal lymph node makes it possible for intravital imaging of live cell interactions in situ. I 
believe it would be of great interest to know whether the CCR7-dependent migration in vivo 
is affected in Cdc42KO B cells. CCL19, CCL21, CXCL12 and CXCL13 are important 
chemotactic factors for migration of cells to and within the spleen. Others and we have seen 
normal migration towards CXCL12 and CXCL13 in vitro, this could be translated in vivo, 
even if homing capacity in vivo is more complex and also requires expression and function of 
adhesion molecules. The draining popliteal lymph node accumulates antigens injected in the 
footpad and thereby potentially attracts more antigen-specific cells independently of Cdc42-
expression; this could be another reason for different homing results between the articles. The 
third reason that may explain the difference in homing capacity of the Cdc42KO B cells is the 
presence or absence of a specific BCR. As mentioned above, Burbage et al. have crossed 
Cdc42fl/flMb1+/Cre mice with mice expressing BCRs with the high affinity for HEL224. This 
gives the adoptive transferred B cells selective advantage for the HEL antigen in a wild type 
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host, compared to our model where no additional antigen was injected after transfer. Burbage 
et al. show that the Cdc42fl/flMb1+/Cre B cells have alterations in development of 
Cdc42fl/flMb1+/Cre B cells, which may make it difficult to distinguish the role of Cdc42 in 
mature cells. To avoid the issue of additive defects from B cell development of Cdc42KO B 
cells we have taken the approach to use inducible deletion of Cdc42 in mature B cells. By this 
method we sustain normal B cell development and colonization of the spleen.  
 
2.3.6 The humoral response to foreign antigens 
In paper I-III we used both TI and TD antigen to evoke immune responses. In paper II we 
used TNP-Ficoll as a TI antigen, to investigate the uptake by MZ B cells and the humoral 
response 7 days later. As discussed above, an impaired switched humoral response was 
observed. In paper III a TI type 1 immune response was simulated by in vitro stimulation of 
Cdc42fl/flMb1+/Cre-ERT2 B cells with LPS. This stimulation led to an increase of IgG2b-
switched B cells, while switching to IgG3 was similar to that in wild type B cells. This is in 
line with data from Guo et al., where they show reduced TNP-specific IgM and IgG3 
response in vivo 7 days after TNP-Ficoll injection of Cdc42fl/flCD19+/Cre B cells187, also 
similar to the reduction found in WKO and cDKO mice in paper II.  
In paper I-IV, we administered in vivo the TD antigens TNP-SRBC and NP/TNP-KLH, 
while anti-CD40 in combination with IL-4 was used to mimic T cell help for in vitro assays. 
Injection of SRBC in mice gives a strong GC reaction, which we also detected in WKO and 
cDKO mice (data not shown). In paper I, TNP was conjugated to SRBC to analyze clonal 
selection of B cells in WKO and cDKO mice. No clonal expansion was detected (data not 
shown), most probably because the antigen itself carries too many epitopes. In paper III, we 
investigated the role of Cdc42 in GC B cells after SRBC injection. Since we know that 
development of Cdc42KO B cells is altered compared to wild type B cells we took advantage 
of the inducible Cdc42fl/flMb1+/Cre-ERT2 mice, where we could delete Cdc42 in mature cells, as 
described above. Both the number of class switched plasma cells and TNP-specific antibody 
titers were similar in Cdc42fl/flMb1+/Cre-ERT2 mice and wild type mice. These antibodies may 
originate from an extrafollicular response since the GC reaction was smaller and IgG1+ cells 
were easily detected in the red pulp and not in B cell follicles in the spleen of 
Cdc42fl/flMb1+/Cre-ERT2 mice. In contrast, Cdc42fl/flMb1+/Cre mice had no detectable 
extrafollicular response and reduced GC formation after influenza A virus immunization188. I 
speculate that the clear difference between these experiments mainly derives from that the 
inducible Cdc42fl/flMb1+/Cre-ERT2 mice have normal B cell development prior to tamoxifen 
treatment. The B cell follicles are thereby already populated with mature B cells that, at site, 
are made deficient of Cdc42. Using the latter model, the function of Cdc42 in B cells during 
GC formation and immune response can be more accurate investigated. 
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In vitro stimulation with anti-CD40 and IL-4 showed similar switching to IgG1 and IgE by 
Cdc42fl/flMb1+/Cre-ERT2 B cells and wild type B cells. In another in vivo experiment both 
Cdc42fl/flCD23+/Cre and Cdc42fl/flMb1+/Cre-ERT2 mice had reduced specific humoral response 
against NP-KLH, even after boost several weeks after the primary injection. These data with 
NP-KLH are in line with what both Guo et al. and Burbage et al. present and are in contrast to 
the normal response we see after SRBC injection or after in vitro stimulation. This difference 
could be due to the potency of SRBC to induce robust immune responses as well as the dose 
administrated. The importance of dose-dependent response was explained in the introduction 
with LTα-deficient mice and NP-OVA as antigen for affinity maturation experiments92.  
Westerberg et al. have previously shown that WKO mice are able to form GC upon SRBC 
immunization, although the response is lower than in wild type mice174. The TD antigen 
response in WKO and cDKO mice was investigated in paper I and II by immunizations with 
either NP- or TNP-KLH. The mice were intraperitoneally injected with TNP-KLH in alum, 
injected a second time three weeks later and sacrificed one week after the boost. The cDKO 
mice had reduced GC formation at day 28 compared to wild type and WKO mice, quantified 
both with flow cytometry and immunohistochemistry. The GCs in cDKO mice had no clear 
polarization (data not shown), detected by light zoned/dark zone B cell markers by flow 
cytometry as described in Victora et al. 2010. TNP-specific antibody titers were measured 
weekly during the experiment. Naïve wild type mice have low TNP-specific reactivity and 
show increase of both IgM and IgG1 antibodies after immunization. In contrast, naïve cDKO 
mice have significant increased titers of hapten-specific IgM antibodies in serum compared to 
wild type mice. TNP-specific IgM titers in cDKO mice are similar to that of wild type and 
WKO mice’s response during the experiment, while the IgG1 response is reduced until the 
boost. Even if less GC B cells were detected at day 28 in cDKO mice, the IgG1 titers were 
similar as in wild type mice at day 28. This normal antibody production after boost in cDKO 
mice in paper II was not observed in paper I (data not shown). This difference may be 
explained by changes in the experimental setup. In paper II, the boost also contained the 
adjuvant alum, which was not the case in paper I. Importantly, all secreted antibodies with 
any reactivity against TNP were detected in paper II, regardless of high or low affinity, 
while we in paper I could distinguish between high- and low-affinity secreted antibodies by 
using low- or high-coupled NP in the ELISA experiment. This enabled us to detect an 
increased ratio of high-affinity over low-affinity IgG1 antibodies produced in wild type and 
WKO mice after boost, which was absent in cDKO mice. 
Since the humoral response was reduced in WKO, cDKO and Cdc42KO mice, we wondered 
weather the cognate T-B cell interaction gave sufficient help for the B cells. B cells from wild 
type, WKO, cDKO and Cdc42fl/flCD23+/Cre mice were therefore pre-activated with IL-4 and 
anti-CD40 for two days followed by OVA-coupling to the BCR and co-cultured with 
enriched CD4+ T cells from OVA-peptide-specific TCR-transgenic OT-II mice. Three days 
after co-culture we measured cytokine production and proliferation of the OVA-specific T 
cells. In paper I, neither polarization of B cells, T cell proliferation nor IL-2 production was 
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different in WKO and cDKO B cell when compared to wild type B cells. In paper III, 
Cdc42fl/flCD23+/Cre B cells showed a reduced uptake of OVA, which may have contributed to 
the reduced T cell number producing IL-2 and increased T cell number producing IFNγ 
compared to co-cultures with wild type B cells. Interestingly, production of IFNγ is 
associated with a Th1 response, upregulation of MHC molecules and B cells switching to 
IgG2b225, which we also see in the Cdc42fl/flCD23+/Cre B cells in vitro. B cells with induced 
Cdc42fl/flMb1+/Cre-ERT2 showed similar results to Cdc42fl/flCD23+/Cre B cells (data not shown). 
Some of the features we observed in Cdc42KO mice and B cells are also found in SAP-
deficient mice, but mainly in T cell-specific SAP-deficiency. In a GC reaction the TFH cells 
require SAP to make a stable T-B cell interaction, and SAP-deficient mice have impaired 
memory B cell and plasma cell numbers, while the extrafollicular pathway is less dependent 
on SAP226,227. SAP-deficient mice have increased percentage of CD4+ T cells producing 
IFNγ, but also IL-2, 30 days after viral infection119. There is a possible link between Cdc42-
deficiency and SAP-deficiency since SAP interacts with PAK-interacting exchange factor 
(PIX) upon SLAM receptor activation. PIX is in turn a GEF for Rac1 and Cdc42 and 
promoting their activation228,229. Our findings in paper III can be compared to the recent 
publication of Burbage et al. Their Cdc42fl/flMb1+/Cre B cells are as efficient as wild type B 
cells in BCR internalizing when biotinylated anti-IgM is bound to the BCR, but have a 
reduction of BCR internalization when antigen is bound, similar to our data in paper III. In 
addition, they found reduced polarization and organization of the antigen inside the 
Cdc42fl/flMb1+/Cre cell188. In vitro both wild type B cells and CD4+ T cells from OT-II mice 
have more proliferation than CD4+ T cells and Cdc42fl/flMb1+/Cre B cells in co-culture, which 
is the opposite to what we found. Burbage et al. have also reported a reduction in cognate 
contact between Cdc42fl/flMb1+/Cre B and T cells compared to wild type B cells in vivo, by 
using Cdc42fl/flMb1+/Cre HEL-specific B cells, CD4+ T cells from OVA-TCR-transgenic OT-
II mice and immunization of HEL-OVA coated microspheres188. As Cdc42KO B cells show 
defect in antigen internalization and intracellular antigen organization, the antigen-
presentation on the MHC class II and activation of cognate T cells may also be impaired.  
 
2.3.6.1 Clonal expansion and somatic hypermutations 
Since we saw reduced GC formation and antibody specificity towards TNP/NP-KLH but 
normal B-T cell interactions in WKO and cDKO mice in paper I and II, we wondered if the 
clonality of B cells selected in the GCs could a source of the altered response. To investigate 
clonal expansion we performed spectratyping of cDNA from the CDR3 region of the BCR. 
CDR1 and CDR2 are in the variable (V) region of the BCR while CDR3 covers the junctions 
between the V, D and J segments. In paper I, mice injected with NP-KLH, showed one 
clonal expansion distinct from the Gaussian distribution in the VH1 spectra. This specific 
peak could represent a monoclonal expansion of cells having the previously described NP-
specific high-affinity mutation in position 33 in VH1-186.2. Since we did not know if WKO 
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and cDKO B cells have a preferential usage of some of the different VH families we decided 
to analyze the most distal which is also the largest family (VH1), the most proximal (VH2) and 
one in mid-distance (VH5) to the D region. While all B cells from wild type mice mainly used 
the VH1 family, variation was seen in WKO and cDKO B cells. To investigate the somatic 
hypermutations (SHM) of expressed BCRs, we prepared cDNA from GC-enriched B cells 
and sequenced the productive BCR genes as described in material and methods. The mutation 
rate was high in IgM and IgG1 BCRs in both wild type and WKO B cells. The NP-specific 
high-affinity mutation, leading to a tryptophan to leucine exchange (W33L), was detected in 
65-80% of the IgG1 clones from wild type and WKO B cells. In cDKO B cells the total 
mutation frequency was decreased in both IgM and IgG1 BCRs. Surprisingly, the majority 
(75%) of the IgG1 clones had the W33L mutation, while the rest of the gene kept germline 
configuration. Unfortunately, only a few cDKO mice gave IgG1 clones to sequence. This 
difficulty in obtaining switched clones from the VH1-family reflects the reduced amount of 
NP-specific IgG1 antibodies found in serum and that the absence of preferential usage of the 
VH1 family. With the help of improved techniques, such as next generation sequencing 
(NGS), we will be able to capture potential clonal expansion outside of the normally used 
VH1 family, and also to be able to get many more sequences compared to our 21-109 
sequences.  
In summary, in paper I we show that upon TD antigen challenge cDKO B cells have normal 
interaction with T cells, but reduced formation and polarization of GC, which leads to a 
reduction of high-affinity antibodies produced. Since we observed cells carrying the high-
affinity mutation in the cDKO mice, but a reduced humoral response, I think it would be 
interesting to investigate the production of antibodies from individual cells by enzyme-linked 
immmunospot (ELISpot). Potentially, B cells lacking both WASp and N-WASp are as 
efficient as wild type B cells at producing high-affinity antibodies, but cannot mount a 
sufficient response due to their low starting number. 
 
2.3.6.2 Similarities and differences between the mouse phenotypes 
Paper I contributes to the existing knowledge that B cells are able to make high-affinity 
antibodies even when the GC reaction is deviant. DOCK8-deficient mice can initiate GC 
formation but not sustain the structure. B cells from these mice can also acquire mutations in 
the CDR regions but lack high-affinity mutations137. CXCR5-deficient mice are able to 
produce high affinity BCRs without being able to form polarized GCs with a dark zone and a 
light zone135. We show reduced GC formation in cDKO mice, by flow cytometry in paper II 
and by immunohistochemistry in paper I, where we also show reduced SHM to foreign 
antigen in cDKO B cells. Nevertheless we do observe the high-affinity mutation. I speculate 
that this could mean that B cells deficient in both WASp and N-WASp have increased 
threshold of BCR activation. Since few mutations other than the high-affinity mutation were 
detected in cDKO B cells, I reason that only the B cells acquiring high affinity during the first 
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round of proliferation are able to survive. As the wild type and WASp-deficient B cells do not 
have increased BCR activation threshold they are able to rearrange and test their BCR several 
times. A potential experiment for investigating the role of BCR signaling in survival and 
SHM of cDKO GC B cells would be to cross cDKO mice with B1-8 transgenic mice bearing 
the membrane bound IgM with high-affinity for NP230. If it is reduced BCR signaling in 
cDKO B cells that causes reduced mutation rate GC B cells from cDKO x B1-8 would have 
more mutations than GC B cells from cDKO mice after NP-KLH immunizations. One reason 
for increased activation threshold is the reduced LFA-1 expression we detected in cDKO B 
cells in paper II. LFA-1, in interaction with its ligand ICAM-1, reduces the amount of 
antigen that is needed to bind the BCR for activation, i.e. LFA-1 activation reduces the 
activating threshold of B cells231. Wild type B cells with normal expression of LFA-1 will 
thus have lower activation threshold than WKO and cDKO B cells. The differences found 
between WKO and cDKO B cells could be caused by the negative regulation N-WASp has 
on BCR signaling. We published in collaboration with Dr Song’s laboratory that N-WASp 
suppresses the BCR-mediated activation of B cells, and that Btk-deficient B cells have 
decreased WASp phosphorylation but increased N-WASp phosphorylation, suggesting 
different roles in BCR signaling186. WKO, cNWKO and cDKO B cells spread on anti-Ig lipid 
bilayer show that WASp activation promotes actin polymerization and B cell spread in the 
contact zone, while N-WASp is inhibiting and removing the polymerized actin and makes the 
synapse structure to contract186. These slightly different actions of WASp and N-WASp can 
be compared to the overall reduction of polymerized actin in Cdc42KO B cells188. As 
mentioned in the introduction, there is a redundancy function between the proteins in actin 
regulation upon BCR stimulation. WASp, N-WASp and WAVE use the Arp2/3 complex for 
actin polymerization. WAVE gets activated by the RhoGTPase Rac that may skew the actin 
polymerization differently than Cdc42 and WASp/N-WASp activation would. It is known 
that Rac and Cdc42 activation give different phenotype. For example, Rac promotes 
lamellipodia formation while Cdc42 promotes filopodia formation194. Could the reduction of 
polymerized actin in Cdc42KO B cells be caused by a preferential Rac-mediated activation of 
WAVE? To elucidate this, Rac activation and phosphorylated WAVE, WASp and N-WASp 
in Cdc42KO B cells could be measured. It would be interesting to investigate the similarities 
and differences in phenotype of mice lacking WASp and N-WASp conditionally in B cells 
and Cdc42-conditional knock out mice, using the same promoter for Cre. 
There are most likely several reasons for why some of our data in paper III differ from data 
presented by Guo et al. and Burbage et al. According to Burbage et al. the reason for the 
striking difference between their study and Guo et al.187 from 2009 is that there is an 
incomplete deletion of Cdc42 in B cells from Cdc42fl/flCD19+/Cre mice compared to their 
Cdc42fl/flMb1+/Cre mice. Even though there might be an incomplete deletion, even in our 
tamoxifen-induced Cdc42 deletion model, I believe that the major underlying cause of the 
differences detected is that the B cells in our model are present in the follicle at the moment 
of Cdc42 deletion. We show that after five constitutive days of tamoxifen treatment 90% of 
the protein is no longer present. The deletion of Cdc42 in the Cdc42fl/flMb1+/Cre-ERT2 mouse is 
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transient and generation of Cre recombinase only occurs as long as tamoxifen, with a half-life 
in serum of 12 hours, is present232. The B cell turnover rate is relatively high in young mice, 
and in a few days the peripheral B cell pool can be repopulated233. The turnover rate in B 
cells decreases with age, which could influence the result of inducible deletion of Cdc42, if 
mice of different ages have been used.  
In our experiments we have used tamoxifen-treated wild type mice that do not express 
Mb1+/Cre-ERT2. Tamoxifen is an antagonist for the estrogen receptor ERT2, which blocks B 
cell maturation by blocking the natural function of estrogen234. Estrogen administration leads 
to BAFF production resulting in an increase in T2 B cells and expansion of autoreactive MZ 
B cells, which have been associated with lupus disease models in mouse235,236. We therefore 
need to make sure that the defects we see in mature B cell development and GC formation are 
not caused by the tamoxifen itself but by the Cdc42 deletion. We have reduced the risk for 
this readout mistake by treating our wild type mice with tamoxifen as well. We have not seen 
any reduction of B cell numbers in wild type mice treated with tamoxifen compared with 
untreated mice. Measuring of BAFF titers in wild type and Cdc42fl/flMb1+/Cre-ERT2 mice 
before, during and after tamoxifen treatment could tell us if tamoxifen is causing a reduction 
in B cell populations by lowering systemic BAFF levels. Potentially there could be an 
increased BAFF production when tamoxifen as an estrogen antagonist is removed.  
We have not investigated the B cell maturation in bone marrow in our inducible 
Cdc42fl/flMb1+/Cre-ERT2 mouse but the reduction of transitional B cells in spleen is similar to 
what Burbage et al. see in their Cdc42fl/flMb1+/Cre mouse. The differences we see in antibody 
titers and plasma cell formation could be due to incomplete deletion of the protein, antigen of 
choice and the time point at which Cdc42 is deleted in the B cells. As Cdc42 is important for 
early development, faulty development and selection at early stages could influence the 
defects we detect in mature cells. I therefore believe it is important to use inducible deletion 
of the protein when studying its relevance in mature cells.  
 
2.3.7 Increased autoreactive milieu in WASp-deficient mice  
Since WAS patients have increased risk of autoimmunity, we were interested in the immune 
response to autoantigens in our WASp-deficient models (paper I). As young WKO and 
cDKO mice do not spontaneously develop autoimmune-like symptoms, we wanted to induce 
autoimmunity in a relatively short time frame. In 1998, Elkon’s laboratory published that four 
weekly injection of syngeneic apoptotic thymocytes leads to break of tolerance against 
autoantigens237. Dr Karlsson’s laboratory developed this model further by using the synthetic 
glucocorticoid hormone dexamethasone as an apoptosis inducer238. In paper I we found that 
apoptotic cells were captured in the marginal zone of the spleen of WT, WKO and cDKO 
mice, and all three strains produced DNA-specific IgG antibodies following four injections. 
Apoptotic cells harbor many self-epitopes, similar to the foreign antigen SRBC. To be able to 
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screen large spectra of autoreactive antibodies in serum we used an autoantibody array of 95 
known autoantigens. Wild type mice showed no autoreactive IgM or IgG before 
immunizations with apoptotic cells. After antigen challenge wild type serum had increased 
titers of autoreactive antibodies, mainly of the IgG subclass. Both WKO and cDKO mice 
were able to mount an autoreactive IgG response after immunization, similar as of wild type 
mice. Pre-immune WKO mice had increased levels of autoreactive IgG antibodies, as 
previously shown183,203. Interestingly, we also detected increased titers of autoantibodies in 
naïve cDKO serum, but of IgM subclass. I would like to compare this to the response we got 
in cDKO mice after injection with the TD antigen NP-KLH. As mentioned earlier, cDKO B 
cells may require BCRs with high affinity to be able to survive after encountering a foreign 
antigen, while WKO B cells may mutate their BCR several times before being selected. The 
same situation might apply here, and the increased threshold for activation may protect the 
cDKO mice by preventing switching to potential autoreactive and pathogenic IgG, as seen in 
WKO mice. In a first attempt to investigate clonal expansion after apoptotic cell injection we 
performed spectratyping on GC-enriched B cells. Unfortunately no clonal expansion could be 
found (data not shown), most probably due to the numerous epitopes on apoptotic cells. It 
would be interesting to immunize mice with NP coupled to an autoantigen that has a 
restricted number of epitopes. Potential autoantigen could be type II collagen leading to 
collagen arthritis239. After immunization, the occurrence of the high-affinity mutation in the 
VH1-186.2 would be investigated. There are specific naturally occurring antibody clones 
found to have reactivity against self, such as phosphorylcholine (PC)240. The main producers 
of this antibody are the B1a B cells in the peritoneal cavity241, which are not altered in our 
WKO and cDKO mice. We have not detected any difference in PC reactivity by ELISA on 
serum from apoptotic cell injected wild type, WKO and cDKO mice (data not shown).  
As we observed for both DNA and the hapten NP/TNP, naïve cDKO mice have increased 
IgM antibodies compared to wild type mice. In paper II we could not detect any differences 
of B1a B cells in the peritoneal cavity of WKO and cDKO mice, while the B1b B cell 
population is reduced in cDKO. It is previously published that WASp-expressing B1a B cells 
have a selective advantage in the peritoneal cavity182,183. One explanation for the difference in 
populations is the different markers that have been used to define the B1 B cell populations in 
peritoneal cavity. B1 B cell numbers are elevated in autoimmune disorders such as SLE, 
Sjögren’s syndrome and rheumatoid arthritis. Of the B1 B cell population the majority is B1a 
B cells, producing natural polyreactive antibodies with low affinity for several antigens. This 
polyreactivity gives recognition of autoantigens, which helps in the clearance of apoptotic 
bodies. Reap et al. stated 1993 that natural antibodies produced by B1 B cells have low 
pathogenicity and are not the source of the pathogenic autoantibodies in autoimmune disease 
(SLE)242. This statement was contradicted in 2010 when Riemekasten’s laboratory published 
that peritoneal B1a cells are able to undergo CSR to IgG and leave the pleural cavity. They 
accumulate in the spleen and kidney and become pathogenic both locally and systemically243. 
Since B1a B cells are linked to polyreactive antibodies and autoimmunity it would be of 
interest to investigate the B1a B cell population in the spleen of both WKO and cDKO mice. 
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In WKO mice, the autoreactive phenotype is found first in older mice. If the B1 B cells are 
expanded with age in WKO mice, the differences found in published data compared to our 
data in paper II could be explained by the age difference of mice used. Potentially, the B1 B 
cells have left the peritoneal cavity in older mice. If we detect elevated B1a B cell number in 
the spleen of older naïve wild type, WKO and cDKO or after apoptotic cell injection it would 
be of interest to perform B cell ELISpot targeting PC on B1a purified B cells to investigate 
the potential autoreactivity of this population.  
WKO and especially cDKO mice have reduced antibody titers upon TI (TNP-Ficoll) and 
reduced GC formation and antibody titers after TD antigen (NP-KLH) immunizations 
compared to wild type mice. Since we detected antibody production against DNA we were 
curious to see if WKO and cDKO mice could form GCs to the same extent as wild type mice 
upon several injections of apoptotic cells. Quantification of GC B cells revealed similar 
numbers in wild type, WKO and cDKO mice, which is a remarkable difference compared to 
the response to a foreign antigen. We next wondered if the structure of the GCs in WKO and 
cDKO mice was similar to that in wild type mice. By staining GC B cells for the specific 
markers distinguishing light and dark zone B cells, we found that the polarization detected in 
wild type mice was missing in GCs in WKO and cDKO mice. This could be due to the 
reduced migration ability of cDKO B cells described in paper II, but also to the abnormal 
localization of follicular dendritic cells (FDCs) discovered in paper I, by staining for CD35 
in the B cell follicle. In wild type mice, CD35+ cells were mainly located in the GC area 
towards the marginal zone where the light zone of the GC is located. In WKO and cDKO 
mice the CD35+ cells covered most parts of the GCs, but also large parts of the B cell 
follicles. The latter defect in WKO and cDKO mice could actually be beneficial for B cell 
selection. If the B cells have reduced migratory ability and cannot relocate between dark zone 
and light zone for proliferation and selection, the unfocused location of FDCs could partly 
compensate for that problem. Although we could not detect polarization of GCs by 
localization of CD35+ cells in WKO and cDKO mice by immunohistochemistry, we should 
explore the presence of specific dark zone GC B cell markers in these mice. There might be 
preferential areas of B cell proliferation in the GC of WKO and cDKO mice, which is 
different from wild type mice. For example further away from the FDCs or proliferation 
everywhere, without specific dark zone formation at all. I favor the latter view because of the 
broad spread of FDCs and the reduced ability of WKO and cDKO B cells to migrate. 
Potential markers apart from CXCR4 would be Bcl-6 and AID to detect GC B cells, normally 
located in the dark zone when polarization occurs139. The spread of FDCs could also lead to 
expansion of autoreactive B cells, since FDCs are a source of BAFF, and BAFF signaling 
promotes survival of autoreactive B cell clones61,95. WKO B cells have normal expression of 
BAFFR on the cell surface as wild type B cells183. Expression of BAFFR on cDKO B cells 
and BAFF titers in cDKO mice are still unknown.  
To be able to detect proliferating cells in vivo, we fed the mice with two different DNA 
incorporating agents 5-ethynyl-2'-deoxyuridine (EdU) and bromodeoxyuridine (BrdU) at 
different time points, starting with EdU. The advantage of using these thymidine analogues in 
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drinking water is that they get incorporated into DNA of proliferating cells without 
influencing the B cell homeostasis. In WKO and cDKO mice we observed GC B cells 
(B220+CD95+GL7+) staying longer in the GC as when compared to wild type GC B cells, 
while the production of plasma cells was similar in all three strains. In a follow-up 
experiment, it would be of importance to look into the bone marrow of apoptotic cell injected 
mice treated with EdU and BrdU. By investigating GC B cells in the spleen we observed that 
wild type B cells proliferate more and seem to leave the spleen at a higher frequency than 
WKO and cDKO GC B cells. To verify that the wild type B cells become plasma cells and 
leave the spleen, and not fall under the limit of detection by diluting their incorporated EdU 
through proliferating, we need to detect EdU+ B cells outside the spleen, for example in 
plasma cells in the bone marrow. For plasma cell migration to the bone marrow CXCL12 and 
CXCR4 are important158. We have detected increased IgG1+ cells in the red pulp of WKO 
and cDKO mice after apoptotic cell injection. This could be a result of reduced migration 
capacity towards CXCL12 in the bone marrow, since WKO and cDKO B cells have reduced 
migratory capacity in in vitro assays. 
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2.4 CONCLUDING REMARKS AND FUTURE PERSPECTIVE 
Mutation in amino acid position 112 is one of the most common mutations in AID causing 
HIGM in human. Our finding of a spontaneous replacement mutation in AIDR112H in mice 
provides a potential and more precise tool than conventional knockout strategies to 
investigate posttranslational regulation of AID in vitro and in vivo.  
When I got registered as a PhD student, I thought of the question “how can an immune 
system fail to respond to foreign pathogens while reacting vigorously to autoantigens?”, as 
shown in WAS patients and other primary immunodeficiencies. During my first conference, I 
got the question slightly differently asked; “how come only 40-70% of the patients develop 
autoimmunity, and not all of them?”. My answer then was that there are different mutations 
in the WASp gene leading to different grades of the disorder. But since then I have thought 
about it. Now 5 years later, our research may have contributed a small piece to answer this 
question. Could N-WASp expression in B cells rescue some functions that are reduced 
because of lack of WASp, as in WAS patients? I would like to investigate the expression of 
N-WASp in WAS patients. Do patients with more severe WAS and autoimmunity have 
normal to elevated expression of N-WASp while patients with milder form of WAS have 
reduced N-WASp expression, which saves them from autoimmune disorders? 
We have shown that both WASp and N-WASp have a unique and a partly redundant function 
in B cells. The selective advantage of B cells expressing the WASp and N-WASp proteins are 
stronger the further differentiated towards MZ B cells the B cells are. Expression of Cdc42 is 
more important early in development of B cells than expression of WASp and N-WASp. 
Potentially WASp and N-WASp, that have been thought to have the same influence on B 
cells upon Cdc42 activation, actually may skew the B cell response differently. More studies 
needs to be done in mice where B cells lacking one or a combination of these three proteins.  
Our data implies that when MZB cells and MZMs are reduced in number, CD11c+ cells 
occupy the marginal zone area instead. This could have an effect on the selection on which 
antigens get into the B cell follicle. WKO and cDKO B cells have reduced expression of 
LFA-1 that may lead to increased BCR activation threshold compared to wild type B cells. 
The interaction of WKO or cDKO B cells with T helper cells is normal while the localization 
of antigen presenting FDCs in WKO and cDKO mice is altered. Several of the above 
mentioned components might be one source for the increased autoreactive milieu in WKO 
and cDKO mice. We have detected several consequences for the immune system when 
Cdc42, WASp and/or N-WASp is lacking in B cells. Since there is not one straight 
interaction pathway from BCR stimulation to actin rearrangement it is difficult to explain all 
phenotypes found in the different mouse strains. When one signaling pathway is removed, 
another one might compensate and the phenotype seen is because of overexpression of a 
compensatory protein instead of reduced expression of the target protein. I would like to 
continue the research on these proteins on an actin cytoskeleton level and maybe understand 
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more of the function of these proteins together or compensating for lack of another proteins 
contributing to the altered immune response in WKO, cDKO and Cdc42KO mice.  
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